| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L21 ZC3H12A USP17L2 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 8.21e-18 | 114 | 176 | 18 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L21 ZC3H12A USP17L2 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 3.90e-17 | 124 | 176 | 18 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L21 ZC3H12A USP17L2 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 2.42e-16 | 137 | 176 | 18 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L21 ZC3H12A USP17L2 USP17L23 USP17L12 USP17L20 USP17L11 CAPN3 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 7.20e-15 | 192 | 176 | 19 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L21 ZC3H12A USP17L2 USP17L23 USP17L12 USP17L20 USP17L11 CAPN3 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 MMP24 FAM111A USP17L17 AEBP1 USP17L6P MMP1 MMP13 USP17L22 MMP14 USP17L15 USP17L8 USP17L13 | 6.87e-10 | 654 | 176 | 25 | GO:0008233 |
| GeneOntologyMolecularFunction | protein serine kinase activity | AKT3 BMP2K MARK1 MAP3K14 RIOK3 MAP3K6 PASK PIK3CA PRKCD AKT1 MAP2K7 WNK4 WNK3 DYRK3 | 4.34e-06 | 363 | 176 | 14 | GO:0106310 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | AKT3 BMP2K MARK1 MAP3K14 RIOK3 PRAG1 MAP3K6 FN3K PASK PIK3C2A PIK3CA FER PRKCD AKT1 FAM20A MAP2K7 ADPGK WNK4 WNK3 DYRK3 | 4.69e-06 | 709 | 176 | 20 | GO:0016773 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | AKT3 BMP2K MARK1 MAP3K14 RIOK3 MAP3K6 PASK PIK3CA PRKCD AKT1 FAM20A MAP2K7 WNK4 WNK3 DYRK3 | 1.02e-05 | 446 | 176 | 15 | GO:0004674 |
| GeneOntologyMolecularFunction | kinase activity | AKT3 BMP2K MARK1 MAP3K14 RIOK3 PRAG1 MAP3K6 FN3K PASK PIK3C2A PIK3CA FER PRKCD AKT1 FAM20A MAP2K7 ADPGK WNK4 WNK3 DYRK3 | 1.40e-05 | 764 | 176 | 20 | GO:0016301 |
| GeneOntologyMolecularFunction | protein kinase activity | AKT3 BMP2K MARK1 MAP3K14 RIOK3 PRAG1 MAP3K6 PASK PIK3CA FER PRKCD AKT1 FAM20A MAP2K7 WNK4 WNK3 DYRK3 | 2.39e-05 | 600 | 176 | 17 | GO:0004672 |
| GeneOntologyMolecularFunction | SUMO ligase activity | 2.53e-05 | 20 | 176 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | AKT3 RNGTT BMP2K MARK1 MAP3K14 RIOK3 PRAG1 MAP3K6 POLR3A FN3K PASK PIK3C2A PIK3CA FER PRKCD AKT1 FAM20A MAP2K7 ADPGK WNK4 WNK3 DYRK3 | 2.78e-05 | 938 | 176 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 7.72e-05 | 50 | 176 | 5 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.02e-04 | 53 | 176 | 5 | GO:0016859 | |
| GeneOntologyMolecularFunction | calcium ion binding | SPTA1 SPTAN1 CAPN3 TRPM2 DAG1 ADGRV1 CUBN CEMIP2 RYR3 PPP3CA PPP3CB SLC25A13 GCA ASTN2 MICU2 MMP13 EFCAB7 PADI2 | 1.15e-04 | 749 | 176 | 18 | GO:0005509 |
| GeneOntologyMolecularFunction | sodium ion binding | 2.28e-04 | 14 | 176 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | phosphatidate phosphatase activity | 2.28e-04 | 14 | 176 | 3 | GO:0008195 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 2.76e-04 | 36 | 176 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | lipid phosphatase activity | 5.88e-04 | 19 | 176 | 3 | GO:0042577 | |
| GeneOntologyMolecularFunction | calmodulin-dependent protein phosphatase activity | 7.59e-04 | 5 | 176 | 2 | GO:0033192 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 1.19e-03 | 24 | 176 | 3 | GO:0120283 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.51e-03 | 26 | 176 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 3-kinase activity | 1.58e-03 | 7 | 176 | 2 | GO:0035005 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity | 1.58e-03 | 7 | 176 | 2 | GO:0046934 | |
| GeneOntologyMolecularFunction | clathrin light chain binding | 1.58e-03 | 7 | 176 | 2 | GO:0032051 | |
| GeneOntologyMolecularFunction | magnesium ion binding | 1.60e-03 | 247 | 176 | 8 | GO:0000287 | |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine phosphatase activity | 2.09e-03 | 8 | 176 | 2 | GO:0004723 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L21 ZC3H12A USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 ABRAXAS2 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 1.24e-17 | 125 | 169 | 18 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L21 ZC3H12A USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 ABRAXAS2 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 1.66e-16 | 144 | 169 | 18 | GO:0070646 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 4.27e-09 | 9 | 169 | 5 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 8.48e-09 | 10 | 169 | 5 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 4.25e-08 | 13 | 169 | 5 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 6.56e-08 | 14 | 169 | 5 | GO:1903299 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 4.88e-07 | 20 | 169 | 5 | GO:0006607 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | RGPD4 ZC3H12A RGPD8 RGPD1 GCKR PPP3CA RGPD3 PRKCD AKT1 EFCAB7 RGPD5 | 6.40e-07 | 195 | 169 | 11 | GO:0006606 |
| GeneOntologyBiologicalProcess | intracellular protein transport | RGPD4 ZC3H12A CLTCL1 RGPD8 COPA RGPD1 VPS54 GCKR PPP3CA AP2A1 AP2A2 NETO1 RGPD3 CLTC PRKCD AKT1 GRIP2 KIF13A EFCAB7 RIC1 RGPD5 | 7.48e-07 | 740 | 169 | 21 | GO:0006886 |
| GeneOntologyBiologicalProcess | import into nucleus | RGPD4 ZC3H12A RGPD8 RGPD1 GCKR PPP3CA RGPD3 PRKCD AKT1 EFCAB7 RGPD5 | 8.64e-07 | 201 | 169 | 11 | GO:0051170 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L21 ZC3H12A USP17L2 USP17L12 USP17L20 USP17L11 WWP1 CAPN3 USP17L24 USP17L5 USP17L10 USP17L19 BIRC6 FN3K USP17L18 ABRAXAS2 USP17L17 TRIM17 USP17L6P PRKCD AKT1 USP17L22 USP17L15 USP17L8 USP17L13 | 2.32e-06 | 1074 | 169 | 25 | GO:0043687 |
| GeneOntologyBiologicalProcess | pancreatic juice secretion | 4.08e-06 | 14 | 169 | 4 | GO:0030157 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to membrane | USP17L2 SPTBN1 DAG1 PIK3CA CLTC AKT1 GRIP2 MMP14 EFCAB7 WNK4 WNK3 | 4.29e-06 | 237 | 169 | 11 | GO:1905475 |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | AKT3 ARID4A SPTA1 TRPM2 LAMA2 VPS54 ADGRV1 DCSTAMP CUBN ITGB6 ZFY LPIN1 PASK NCOR1 PPP3CB PIK3CA EHMT1 AKT1 GNAS IL1A CADPS2 WNK4 WNK3 DYRK3 | 4.60e-06 | 1043 | 169 | 24 | GO:0048871 |
| GeneOntologyBiologicalProcess | carbohydrate biosynthetic process | RGPD4 RGPD8 RGPD1 PGM1 PASK AP2A1 SLC25A13 RGPD3 CLTC GYG2 AKT1 | 6.36e-06 | 247 | 169 | 11 | GO:0016051 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L21 ZC3H12A USP17L2 USP17L12 USP17L20 USP17L11 WWP1 CAPN3 USP17L24 USP17L5 USP17L10 USP17L19 BIRC6 USP17L18 ABRAXAS2 USP17L17 TRIM17 USP17L6P AKT1 USP17L22 USP17L15 USP17L8 USP17L13 | 8.65e-06 | 1009 | 169 | 23 | GO:0070647 |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 1.34e-05 | 132 | 169 | 8 | GO:0043255 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.40e-05 | 38 | 169 | 5 | GO:0000413 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 2.16e-05 | 231 | 169 | 10 | GO:0006109 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | RGPD4 RGPD8 RGPD1 GCKR GBA2 LANCL2 PGM1 PASK NCOR1 AP2A1 PIK3CA SLC25A13 RGPD3 CLTC GYG2 AKT1 ADPGK | 2.40e-05 | 646 | 169 | 17 | GO:0005975 |
| GeneOntologyBiologicalProcess | glucose metabolic process | RGPD4 RGPD8 RGPD1 GCKR PGM1 PIK3CA SLC25A13 RGPD3 AKT1 ADPGK | 3.45e-05 | 244 | 169 | 10 | GO:0006006 |
| GeneOntologyBiologicalProcess | polysaccharide biosynthetic process | 3.77e-05 | 76 | 169 | 6 | GO:0000271 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | RGPD4 ZC3H12A RGPD8 RGPD1 GCKR PPP3CA PPP3CB RGPD3 PRKCD AKT1 EFCAB7 RGPD5 | 4.59e-05 | 362 | 169 | 12 | GO:0034504 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | AKT3 DSCAM SPTA1 SPTAN1 SPTBN1 ITGA1 GBA2 PIK3C2A WASHC5 PIK3CA FER PRKCD DAAM2 AKT1 GRIP2 WNK3 | 5.10e-05 | 618 | 169 | 16 | GO:0090066 |
| GeneOntologyBiologicalProcess | regulation of cellular component size | AKT3 DSCAM SPTA1 SPTAN1 SPTBN1 GBA2 WASHC5 PIK3CA FER PRKCD DAAM2 AKT1 WNK3 | 5.17e-05 | 426 | 169 | 13 | GO:0032535 |
| GeneOntologyBiologicalProcess | response to temperature stimulus | 5.63e-05 | 208 | 169 | 9 | GO:0009266 | |
| GeneOntologyBiologicalProcess | post-embryonic animal morphogenesis | 6.22e-05 | 10 | 169 | 3 | GO:0009886 | |
| GeneOntologyBiologicalProcess | spermine biosynthetic process | 6.67e-05 | 2 | 169 | 2 | GO:0006597 | |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD4 ZC3H12A RGPD8 RGPD1 GCKR INPP4B PPP3CA RGPD3 PRKCD AKT1 EFCAB7 RGPD5 | 6.94e-05 | 378 | 169 | 12 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD4 ZC3H12A RGPD8 RGPD1 GCKR INPP4B PPP3CA RGPD3 PRKCD AKT1 EFCAB7 RGPD5 | 6.94e-05 | 378 | 169 | 12 | GO:0006913 |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 7.96e-05 | 54 | 169 | 5 | GO:0018208 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell periphery | 8.52e-05 | 171 | 169 | 8 | GO:1904375 | |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | 9.29e-05 | 222 | 169 | 9 | GO:0008154 | |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | 1.08e-04 | 177 | 169 | 8 | GO:0008064 | |
| GeneOntologyBiologicalProcess | regulation of actin filament length | 1.22e-04 | 180 | 169 | 8 | GO:0030832 | |
| GeneOntologyBiologicalProcess | hexose metabolic process | RGPD4 RGPD8 RGPD1 GCKR PGM1 PIK3CA SLC25A13 RGPD3 AKT1 ADPGK | 1.22e-04 | 284 | 169 | 10 | GO:0019318 |
| GeneOntologyBiologicalProcess | regulation of cellular localization | DHX36 ZC3H12A USP17L2 SPTBN1 TRPM2 DAG1 INPP4B PPP3CA PPP3CB PIK3CA TRIM17 CLTC PRKCD ASTN2 AKT1 GRIP2 GNAS IL1A MMP13 MMP14 EFCAB7 WNK4 WNK3 | 1.47e-04 | 1212 | 169 | 23 | GO:0060341 |
| GeneOntologyBiologicalProcess | actin filament polymerization | 1.77e-04 | 190 | 169 | 8 | GO:0030041 | |
| GeneOntologyBiologicalProcess | secretion by tissue | 1.80e-04 | 64 | 169 | 5 | GO:0032941 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transport | 1.84e-04 | 101 | 169 | 6 | GO:0002028 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | IFT20 SPTBN1 DAG1 NETO1 CLTC AKT1 GRIP2 MMP14 KIF13A EFCAB7 WNK4 WNK3 | 1.95e-04 | 422 | 169 | 12 | GO:1990778 |
| GeneOntologyBiologicalProcess | spermidine biosynthetic process | 1.99e-04 | 3 | 169 | 2 | GO:0008295 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD4 ZC3H12A CLTCL1 RGPD8 COPA IFT20 RGPD1 VPS54 GCKR INPP4B PPP3CA AP2A1 AP2A2 SNX32 WASHC5 NETO1 RGPD3 CLTC PRKCD AKT1 GRIP2 GNAS KIF13A EFCAB7 RIC1 RGPD5 | 2.14e-04 | 1496 | 169 | 26 | GO:0046907 |
| GeneOntologyBiologicalProcess | polyamine biosynthetic process | 2.29e-04 | 15 | 169 | 3 | GO:0006596 | |
| GeneOntologyBiologicalProcess | regulation of protein localization | ZC3H12A USP17L2 SPTBN1 TRPM2 DAG1 PPP3CA PPP3CB PIK3CA TRIM17 CLTC PRKCD ASTN2 AKT1 GRIP2 GNAS IL1A MMP13 MMP14 EFCAB7 WNK4 WNK3 | 2.29e-04 | 1087 | 169 | 21 | GO:0032880 |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | RGPD4 RGPD8 RGPD1 GCKR PGM1 PIK3CA SLC25A13 RGPD3 AKT1 ADPGK | 2.48e-04 | 310 | 169 | 10 | GO:0005996 |
| GeneOntologyBiologicalProcess | regulation of actin filament polymerization | 3.06e-04 | 156 | 169 | 7 | GO:0030833 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 3.08e-04 | 111 | 169 | 6 | GO:0006094 | |
| GeneOntologyBiologicalProcess | negative regulation of carbohydrate metabolic process | 3.13e-04 | 72 | 169 | 5 | GO:0045912 | |
| GeneOntologyBiologicalProcess | cellular response to peptide hormone stimulus | AKT3 LPIN3 LPIN1 PPP3CA PIK3C2A PIK3CA LPIN2 FER PRKCD AKT1 GNAS | 3.17e-04 | 381 | 169 | 11 | GO:0071375 |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | TRERF1 AKT3 VPS54 LANCL2 LPIN3 LPIN1 NCOR1 PPP3CA PIK3C2A PIK3CA LPIN2 FER PRKCD AKT1 GNAS PADI2 | 3.27e-04 | 727 | 169 | 16 | GO:0032870 |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | RGPD4 ZC3H12A RGPD8 RGPD1 VPS54 GCKR CUBN PPP3CA RGPD3 PRKCD AKT1 EFCAB7 RGPD5 | 3.36e-04 | 515 | 169 | 13 | GO:0072594 |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | SPTA1 SPTAN1 SPTBN1 TRPM2 GBA2 WASHC5 PIK3CA FER PRKCD DAAM2 IL1A | 3.38e-04 | 384 | 169 | 11 | GO:0032956 |
| GeneOntologyBiologicalProcess | energy derivation by oxidation of organic compounds | 3.46e-04 | 385 | 169 | 11 | GO:0015980 | |
| GeneOntologyBiologicalProcess | negative regulation of protein localization to membrane | 3.48e-04 | 41 | 169 | 4 | GO:1905476 | |
| GeneOntologyBiologicalProcess | response to hormone | TRERF1 AKT3 DAG1 VPS54 LANCL2 LPIN3 LPIN1 NCOR1 PPP3CA PIK3C2A PIK3CA EIF2B5 LPIN2 FER PRKCD AKT1 GNAS MMP13 MMP14 PADI2 | 3.54e-04 | 1042 | 169 | 20 | GO:0009725 |
| GeneOntologyBiologicalProcess | response to calcium ion | 3.71e-04 | 161 | 169 | 7 | GO:0051592 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 3.73e-04 | 115 | 169 | 6 | GO:0019319 | |
| GeneOntologyBiologicalProcess | positive regulation of sodium ion transport | 3.82e-04 | 42 | 169 | 4 | GO:0010765 | |
| GeneOntologyBiologicalProcess | positive regulation of endodeoxyribonuclease activity | 3.96e-04 | 4 | 169 | 2 | GO:0032079 | |
| GeneOntologyBiologicalProcess | negative regulation of hyaluronan biosynthetic process | 3.96e-04 | 4 | 169 | 2 | GO:1900126 | |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | 4.10e-04 | 271 | 169 | 9 | GO:0032869 | |
| GeneOntologyBiologicalProcess | generation of precursor metabolites and energy | VPS54 PGM1 PASK NCOR1 PIK3CA SLC25A13 COQ9 DLD GYG2 AKT1 GNAS NNT ADPGK | 4.33e-04 | 529 | 169 | 13 | GO:0006091 |
| GeneOntologyBiologicalProcess | response to peptide hormone | AKT3 DAG1 LPIN3 LPIN1 PPP3CA PIK3C2A PIK3CA EIF2B5 LPIN2 FER PRKCD AKT1 GNAS | 4.40e-04 | 530 | 169 | 13 | GO:0043434 |
| GeneOntologyBiologicalProcess | sodium ion transport | 4.56e-04 | 275 | 169 | 9 | GO:0006814 | |
| GeneOntologyBiologicalProcess | response to heat | 4.89e-04 | 121 | 169 | 6 | GO:0009408 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 4.89e-04 | 121 | 169 | 6 | GO:0046364 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | AKT3 SLC39A2 CAPN3 TRPM2 RYR3 MELTF PPP3CA PPP3CB PIK3C2A NETO1 SLC25A13 CLTC SCN8A SCN9A NIPA2 AKT1 GNAS MICU2 NNT WNK4 WNK3 | 5.23e-04 | 1157 | 169 | 21 | GO:0006812 |
| GeneOntologyBiologicalProcess | polyamine metabolic process | 5.56e-04 | 20 | 169 | 3 | GO:0006595 | |
| GeneOntologyBiologicalProcess | metal ion transport | AKT3 SLC39A2 CAPN3 TRPM2 RYR3 MELTF PPP3CA PPP3CB PIK3C2A NETO1 CLTC SCN8A SCN9A NIPA2 AKT1 GNAS MICU2 WNK4 WNK3 | 5.66e-04 | 1000 | 169 | 19 | GO:0030001 |
| GeneOntologyBiologicalProcess | cellular component disassembly | SPTA1 SPTAN1 SPTBN1 VPS54 LPIN1 MELTF PIK3CA CLTC FER MMP1 ASCC3 MMP13 MMP14 DYRK3 | 5.77e-04 | 617 | 169 | 14 | GO:0022411 |
| GeneOntologyBiologicalProcess | regulation of polysaccharide biosynthetic process | 5.89e-04 | 47 | 169 | 4 | GO:0032885 | |
| GeneOntologyBiologicalProcess | polysaccharide metabolic process | 6.06e-04 | 126 | 169 | 6 | GO:0005976 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 6.37e-04 | 84 | 169 | 5 | GO:1903053 | |
| GeneOntologyBiologicalProcess | positive regulation of deoxyribonuclease activity | 6.57e-04 | 5 | 169 | 2 | GO:0032077 | |
| GeneOntologyBiologicalProcess | negative regulation of pancreatic juice secretion | 6.57e-04 | 5 | 169 | 2 | GO:0090188 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to plasma membrane | 6.59e-04 | 128 | 169 | 6 | GO:1903076 | |
| GeneOntologyBiologicalProcess | protein localization to membrane | USP17L2 IFT20 SPTBN1 CAPN3 DAG1 NETO1 PIK3CA CLTC AKT1 GRIP2 MMP14 KIF13A EFCAB7 WNK4 WNK3 | 7.13e-04 | 705 | 169 | 15 | GO:0072657 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to membrane | 7.14e-04 | 130 | 169 | 6 | GO:1905477 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-3-phosphate biosynthetic process | 7.42e-04 | 22 | 169 | 3 | GO:0036092 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | TRERF1 DHX36 AKT3 ZC3H12A TRPM2 DAG1 VPS54 LANCL2 RYR3 ADH5 LPIN3 LPIN1 PPP3CA PPP3CB PIK3C2A PIK3CA LPIN2 FER PRKCD AKT1 GNAL GNAS IL1A MAP2K7 | 7.69e-04 | 1450 | 169 | 24 | GO:1901701 |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 8.37e-04 | 134 | 169 | 6 | GO:0010906 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 8.48e-04 | 300 | 169 | 9 | GO:0110053 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | AKT3 SLC39A2 WWP1 CAPN3 TRPM2 RYR3 MELTF PPP3CA PPP3CB PIK3C2A NETO1 SLC25A13 CLTC SCN8A SCN9A NIPA2 AKT1 GNAS MICU2 NNT WNK4 WNK3 PCYOX1 | 8.57e-04 | 1374 | 169 | 23 | GO:0006811 |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 8.67e-04 | 52 | 169 | 4 | GO:0030835 | |
| GeneOntologyBiologicalProcess | post-embryonic development | 8.70e-04 | 135 | 169 | 6 | GO:0009791 | |
| GeneOntologyBiologicalProcess | clathrin-dependent endocytosis | 9.32e-04 | 53 | 169 | 4 | GO:0072583 | |
| GeneOntologyBiologicalProcess | collagen catabolic process | 9.32e-04 | 53 | 169 | 4 | GO:0030574 | |
| GeneOntologyBiologicalProcess | Sertoli cell development | 9.64e-04 | 24 | 169 | 3 | GO:0060009 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclease activity | 9.80e-04 | 6 | 169 | 2 | GO:0032075 | |
| GeneOntologyBiologicalProcess | spermine metabolic process | 9.80e-04 | 6 | 169 | 2 | GO:0008215 | |
| GeneOntologyBiologicalProcess | cellular response to environmental stimulus | 1.00e-03 | 371 | 169 | 10 | GO:0104004 | |
| GeneOntologyBiologicalProcess | cellular response to abiotic stimulus | 1.00e-03 | 371 | 169 | 10 | GO:0071214 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | SPTA1 SPTAN1 SPTBN1 TRPM2 GBA2 WASHC5 PIK3CA FER PRKCD DAAM2 IL1A | 1.00e-03 | 438 | 169 | 11 | GO:0032970 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection assembly | 1.03e-03 | 248 | 169 | 8 | GO:0120032 | |
| GeneOntologyBiologicalProcess | glycogen biosynthetic process | 1.07e-03 | 55 | 169 | 4 | GO:0005978 | |
| GeneOntologyBiologicalProcess | glucan biosynthetic process | 1.07e-03 | 55 | 169 | 4 | GO:0009250 | |
| GeneOntologyBiologicalProcess | regulation of cell projection assembly | 1.12e-03 | 251 | 169 | 8 | GO:0060491 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.13e-03 | 377 | 169 | 10 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.15e-03 | 378 | 169 | 10 | GO:0043062 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 3.31e-07 | 8 | 176 | 4 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | RGPD4 USP17L21 ZC3H12A USP17L2 USP17L12 RGPD8 COPA USP17L20 USP17L11 RGPD1 USP17L5 USP17L10 USP17L19 LBR DCSTAMP GBA2 RYR3 USP17L18 LPIN3 LPIN1 USP17L17 RGPD3 LPIN2 XXYLT1 USP17L6P USP17L22 ADPGK USP17L15 USP17L8 USP17L13 | 6.70e-07 | 1327 | 176 | 30 | GO:0042175 |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 9.80e-07 | 10 | 176 | 4 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 4.55e-06 | 14 | 176 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.36e-05 | 18 | 176 | 4 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 2.12e-05 | 20 | 176 | 4 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 2.60e-05 | 21 | 176 | 4 | GO:0106068 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 2.80e-05 | 185 | 176 | 9 | GO:0009898 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L21 ZC3H12A USP17L2 USP17L12 COPA USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 LBR DCSTAMP GBA2 RYR3 USP17L18 LPIN3 LPIN1 USP17L17 LPIN2 XXYLT1 USP17L6P USP17L22 ADPGK USP17L15 USP17L8 USP17L13 | 3.18e-05 | 1293 | 176 | 26 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L21 ZC3H12A USP17L2 USP17L12 COPA USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 LBR DCSTAMP GBA2 RYR3 USP17L18 LPIN3 LPIN1 USP17L17 LPIN2 XXYLT1 USP17L6P USP17L22 ADPGK USP17L15 USP17L8 USP17L13 | 3.44e-05 | 1299 | 176 | 26 | GO:0098827 |
| GeneOntologyCellularComponent | Z disc | 4.30e-05 | 151 | 176 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | spectrin | 4.75e-05 | 9 | 176 | 3 | GO:0008091 | |
| GeneOntologyCellularComponent | I band | 8.39e-05 | 166 | 176 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | myofibril | SPTAN1 SPTBN1 CAPN3 DAG1 PARVB PGM1 RYR3 PPP3CA PPP3CB SCN8A | 1.11e-04 | 273 | 176 | 10 | GO:0030016 |
| GeneOntologyCellularComponent | endolysosome | 1.12e-04 | 30 | 176 | 4 | GO:0036019 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 1.50e-04 | 230 | 176 | 9 | GO:0098562 | |
| GeneOntologyCellularComponent | cuticular plate | 1.58e-04 | 13 | 176 | 3 | GO:0032437 | |
| GeneOntologyCellularComponent | contractile muscle fiber | SPTAN1 SPTBN1 CAPN3 DAG1 PARVB PGM1 RYR3 PPP3CA PPP3CB SCN8A | 1.81e-04 | 290 | 176 | 10 | GO:0043292 |
| GeneOntologyCellularComponent | sarcolemma | 2.13e-04 | 190 | 176 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | nuclear pore | 2.14e-04 | 101 | 176 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | vesicle coat | 2.53e-04 | 67 | 176 | 5 | GO:0030120 | |
| GeneOntologyCellularComponent | sarcomere | 2.70e-04 | 249 | 176 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | clathrin vesicle coat | 2.87e-04 | 38 | 176 | 4 | GO:0030125 | |
| GeneOntologyCellularComponent | trans-Golgi network membrane | 3.74e-04 | 112 | 176 | 6 | GO:0032588 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 4.12e-04 | 114 | 176 | 6 | GO:0005798 | |
| GeneOntologyCellularComponent | clathrin coat of trans-Golgi network vesicle | 4.36e-04 | 18 | 176 | 3 | GO:0030130 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 5.77e-04 | 80 | 176 | 5 | GO:0005905 | |
| GeneOntologyCellularComponent | endolysosome membrane | 6.02e-04 | 20 | 176 | 3 | GO:0036020 | |
| GeneOntologyCellularComponent | clathrin coat of coated pit | 6.98e-04 | 21 | 176 | 3 | GO:0030132 | |
| GeneOntologyCellularComponent | trans-Golgi network transport vesicle membrane | 8.03e-04 | 22 | 176 | 3 | GO:0012510 | |
| GeneOntologyCellularComponent | calcineurin complex | 1.03e-03 | 6 | 176 | 2 | GO:0005955 | |
| GeneOntologyCellularComponent | trans-Golgi network | 1.18e-03 | 306 | 176 | 9 | GO:0005802 | |
| GeneOntologyCellularComponent | clathrin coat | 1.27e-03 | 56 | 176 | 4 | GO:0030118 | |
| GeneOntologyCellularComponent | glutamatergic synapse | MARK1 SPTAN1 SPTBN1 DAG1 SEMA4C PPP3CA PPP3CB SHANK2 AP2A1 NETO1 CLTC SCN8A AKT1 ADGRA1 GRIP2 CADPS2 | 1.52e-03 | 817 | 176 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 1.74e-03 | 61 | 176 | 4 | GO:0030660 | |
| GeneOntologyCellularComponent | coated membrane | 2.04e-03 | 106 | 176 | 5 | GO:0048475 | |
| GeneOntologyCellularComponent | membrane coat | 2.04e-03 | 106 | 176 | 5 | GO:0030117 | |
| GeneOntologyCellularComponent | postsynapse | MARK1 SPTAN1 SPTBN1 LAMA2 DAG1 SEMA4C PPP3CA SHANK2 AP2A1 AP2A2 NETO1 CLTC SCN8A PRKCD AKT1 ADGRA1 GRIP2 CADPS2 | 2.41e-03 | 1018 | 176 | 18 | GO:0098794 |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 2.44e-03 | 9 | 176 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | clathrin complex | 2.44e-03 | 9 | 176 | 2 | GO:0071439 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 3.41e-03 | 230 | 176 | 7 | GO:0019898 | |
| GeneOntologyCellularComponent | coated vesicle | 3.54e-03 | 360 | 176 | 9 | GO:0030135 | |
| GeneOntologyCellularComponent | postsynaptic endocytic zone | 3.69e-03 | 11 | 176 | 2 | GO:0098843 | |
| GeneOntologyCellularComponent | anchoring junction | MPP3 SPTAN1 DAG1 PARVB ITGA1 PRAG1 ITGB6 PPP3CA PIK3CA CLTC FER PRKCD AKT1 MMP13 MMP14 WNK4 WNK3 | 3.69e-03 | 976 | 176 | 17 | GO:0070161 |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | CLTCL1 VPS54 BIRC6 MMP24 PIK3C2A GOLGA8CP CLTC GNAS KIF13A RIC1 | 4.43e-03 | 443 | 176 | 10 | GO:0098791 |
| GeneOntologyCellularComponent | trans-Golgi network transport vesicle | 4.61e-03 | 40 | 176 | 3 | GO:0030140 | |
| HumanPheno | EEG with focal epileptiform discharges | 5.00e-06 | 118 | 57 | 9 | HP:0011185 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 7.60e-06 | 107 | 132 | 8 | MP:0003694 | |
| MousePheno | failure of blastocyst formation | 9.71e-06 | 31 | 132 | 5 | MP:0012129 | |
| MousePheno | abnormal blastocyst hatching | 1.14e-05 | 113 | 132 | 8 | MP:0003693 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 1.27e-05 | 16 | 132 | 4 | MP:0003701 | |
| MousePheno | abnormal blastocyst formation | 3.10e-05 | 39 | 132 | 5 | MP:0012128 | |
| MousePheno | increased trophectoderm apoptosis | 4.45e-05 | 8 | 132 | 3 | MP:0012119 | |
| MousePheno | increased sarcoma incidence | 5.00e-05 | 102 | 132 | 7 | MP:0002032 | |
| MousePheno | abnormal cranial cavity morphology | 8.85e-05 | 2 | 132 | 2 | MP:0030076 | |
| MousePheno | abnormal morula morphology | 9.67e-05 | 26 | 132 | 4 | MP:0012058 | |
| MousePheno | increased energy expenditure | 1.00e-04 | 196 | 132 | 9 | MP:0004889 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 1.37e-04 | 160 | 132 | 8 | MP:0005659 | |
| MousePheno | demyelination | 1.50e-04 | 85 | 132 | 6 | MP:0000921 | |
| MousePheno | decreased tumor latency | 1.72e-04 | 30 | 132 | 4 | MP:0010308 | |
| MousePheno | abnormal preimplantation embryo development | 2.16e-04 | 171 | 132 | 8 | MP:0009781 | |
| MousePheno | dystrophic muscle | 2.23e-04 | 32 | 132 | 4 | MP:0000752 | |
| MousePheno | dilated brain ventricle | 2.32e-04 | 92 | 132 | 6 | MP:0012676 | |
| MousePheno | abnormal tumor latency | 2.83e-04 | 34 | 132 | 4 | MP:0010307 | |
| MousePheno | abnormal eye electrophysiology | 3.12e-04 | 228 | 132 | 9 | MP:0005551 | |
| MousePheno | decreased regulatory T cell number | 3.40e-04 | 64 | 132 | 5 | MP:0004974 | |
| MousePheno | decreased susceptibility to weight gain | 3.82e-04 | 186 | 132 | 8 | MP:0010182 | |
| MousePheno | increased IgA level | 3.92e-04 | 66 | 132 | 5 | MP:0002495 | |
| Domain | HABP4_PAI-RBP1 | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 4.78e-22 | 16 | 173 | 12 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 4.78e-22 | 16 | 173 | 12 | IPR006861 |
| Domain | USP_CS | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L8 USP17L13 | 1.02e-15 | 66 | 173 | 14 | IPR018200 |
| Domain | USP_1 | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L8 USP17L13 | 2.48e-15 | 70 | 173 | 14 | PS00972 |
| Domain | UCH | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L8 USP17L13 | 3.06e-15 | 71 | 173 | 14 | PF00443 |
| Domain | USP_2 | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L8 USP17L13 | 3.06e-15 | 71 | 173 | 14 | PS00973 |
| Domain | USP_3 | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L8 USP17L13 | 3.77e-15 | 72 | 173 | 14 | PS50235 |
| Domain | USP_dom | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L8 USP17L13 | 3.77e-15 | 72 | 173 | 14 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L8 USP17L13 | 3.77e-15 | 72 | 173 | 14 | IPR001394 |
| Domain | Grip | 2.84e-08 | 11 | 173 | 5 | SM00755 | |
| Domain | GRIP | 2.84e-08 | 11 | 173 | 5 | PF01465 | |
| Domain | Ran_BP1 | 4.84e-08 | 12 | 173 | 5 | PF00638 | |
| Domain | RANBD1 | 4.84e-08 | 12 | 173 | 5 | PS50196 | |
| Domain | GRIP_dom | 4.84e-08 | 12 | 173 | 5 | IPR000237 | |
| Domain | GRIP | 4.84e-08 | 12 | 173 | 5 | PS50913 | |
| Domain | RanBD | 7.80e-08 | 13 | 173 | 5 | SM00160 | |
| Domain | Ran_bind_dom | 7.80e-08 | 13 | 173 | 5 | IPR000156 | |
| Domain | Rab_bind | 2.44e-07 | 7 | 173 | 4 | PF16704 | |
| Domain | GCC2_Rab_bind | 2.44e-07 | 7 | 173 | 4 | IPR032023 | |
| Domain | Lipin_N | 7.81e-07 | 3 | 173 | 3 | IPR007651 | |
| Domain | Lipin_mid | 7.81e-07 | 3 | 173 | 3 | IPR031703 | |
| Domain | Lipin_N | 7.81e-07 | 3 | 173 | 3 | PF04571 | |
| Domain | Lipin_mid | 7.81e-07 | 3 | 173 | 3 | PF16876 | |
| Domain | - | 1.43e-06 | 10 | 173 | 4 | 1.10.220.60 | |
| Domain | Kinase-like_dom | AKT3 BMP2K MARK1 MAP3K14 RIOK3 PRAG1 MAP3K6 FN3K PASK PIK3C2A PIK3CA FER PRKCD AKT1 MAP2K7 WNK4 WNK3 DYRK3 | 3.01e-06 | 542 | 173 | 18 | IPR011009 |
| Domain | LNS2 | 1.53e-05 | 6 | 173 | 3 | IPR013209 | |
| Domain | LNS2 | 1.53e-05 | 6 | 173 | 3 | SM00775 | |
| Domain | LNS2 | 1.53e-05 | 6 | 173 | 3 | PF08235 | |
| Domain | LNS2/PITP | 1.53e-05 | 6 | 173 | 3 | IPR031315 | |
| Domain | Hemopexin_CS | 1.54e-05 | 17 | 173 | 4 | IPR018486 | |
| Domain | Pept_M10A_stromelysin-type | 1.97e-05 | 18 | 173 | 4 | IPR016293 | |
| Domain | RNase_Zc3h12a | 2.66e-05 | 7 | 173 | 3 | PF11977 | |
| Domain | RNase_Zc3h12_NYN | 2.66e-05 | 7 | 173 | 3 | IPR021869 | |
| Domain | PG_binding_1 | 3.07e-05 | 20 | 173 | 4 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 3.07e-05 | 20 | 173 | 4 | IPR002477 | |
| Domain | S_TKc | AKT3 BMP2K MARK1 MAP3K14 PRAG1 MAP3K6 PASK PRKCD AKT1 MAP2K7 WNK4 WNK3 DYRK3 | 3.12e-05 | 359 | 173 | 13 | SM00220 |
| Domain | Prot_kinase_dom | AKT3 BMP2K MARK1 MAP3K14 RIOK3 PRAG1 MAP3K6 PASK FER PRKCD AKT1 MAP2K7 WNK4 WNK3 DYRK3 | 5.19e-05 | 489 | 173 | 15 | IPR000719 |
| Domain | Hemopexin-like_dom | 5.49e-05 | 23 | 173 | 4 | IPR000585 | |
| Domain | Hemopexin-like_repeat | 5.49e-05 | 23 | 173 | 4 | IPR018487 | |
| Domain | HEMOPEXIN | 5.49e-05 | 23 | 173 | 4 | PS00024 | |
| Domain | - | 5.49e-05 | 23 | 173 | 4 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 5.49e-05 | 23 | 173 | 4 | PS51642 | |
| Domain | HX | 5.49e-05 | 23 | 173 | 4 | SM00120 | |
| Domain | M10A_MMP | 5.49e-05 | 23 | 173 | 4 | IPR033739 | |
| Domain | Hemopexin | 5.49e-05 | 23 | 173 | 4 | PF00045 | |
| Domain | Pept_M10A | 5.49e-05 | 23 | 173 | 4 | IPR021190 | |
| Domain | PROTEIN_KINASE_DOM | AKT3 BMP2K MARK1 MAP3K14 RIOK3 PRAG1 MAP3K6 PASK FER PRKCD AKT1 MAP2K7 WNK4 WNK3 DYRK3 | 5.69e-05 | 493 | 173 | 15 | PS50011 |
| Domain | Pkinase | AKT3 BMP2K MARK1 MAP3K14 PRAG1 MAP3K6 PASK PRKCD AKT1 MAP2K7 WNK4 WNK3 DYRK3 | 5.74e-05 | 381 | 173 | 13 | PF00069 |
| Domain | Peptidase_M10 | 6.54e-05 | 24 | 173 | 4 | PF00413 | |
| Domain | ARM-type_fold | CLTCL1 PSMD1 HEATR1 RYR3 AP2A1 AP2A2 PIK3C2A CEBPZ PIK3CA EIF2B5 CLTC DAAM2 | 7.85e-05 | 339 | 173 | 12 | IPR016024 |
| Domain | Gprotein_alpha_S | 8.53e-05 | 2 | 173 | 2 | IPR000367 | |
| Domain | Clathrin_H-chain_propeller_rpt | 8.53e-05 | 2 | 173 | 2 | IPR022365 | |
| Domain | Clathrin-link | 8.53e-05 | 2 | 173 | 2 | PF09268 | |
| Domain | - | 8.53e-05 | 2 | 173 | 2 | 2.130.10.110 | |
| Domain | PABS | 8.53e-05 | 2 | 173 | 2 | IPR030374 | |
| Domain | PABS_CS | 8.53e-05 | 2 | 173 | 2 | IPR030373 | |
| Domain | - | 8.53e-05 | 2 | 173 | 2 | 2.60.40.1030 | |
| Domain | PABS_2 | 8.53e-05 | 2 | 173 | 2 | PS51006 | |
| Domain | Clathrin_heavy_chain | 8.53e-05 | 2 | 173 | 2 | IPR016341 | |
| Domain | Clathrin_a-adaptin_app_Ig-like | 8.53e-05 | 2 | 173 | 2 | IPR013038 | |
| Domain | PABS_1 | 8.53e-05 | 2 | 173 | 2 | PS01330 | |
| Domain | Clathrin_H-chain_propeller_N | 8.53e-05 | 2 | 173 | 2 | IPR001473 | |
| Domain | Clathrin_H-chain_link/propller | 8.53e-05 | 2 | 173 | 2 | IPR016025 | |
| Domain | Clathrin_propel | 8.53e-05 | 2 | 173 | 2 | PF01394 | |
| Domain | AP2_complex_asu | 8.53e-05 | 2 | 173 | 2 | IPR017104 | |
| Domain | Clathrin_a-adaptin_app_sub_C | 8.53e-05 | 2 | 173 | 2 | IPR003164 | |
| Domain | Clathrin_H-chain_linker_core | 8.53e-05 | 2 | 173 | 2 | IPR015348 | |
| Domain | Alpha_adaptin_C | 8.53e-05 | 2 | 173 | 2 | PF02296 | |
| Domain | Ser/Thr_kinase_AS | AKT3 BMP2K MARK1 MAP3K14 MAP3K6 PASK PRKCD AKT1 MAP2K7 WNK4 WNK3 DYRK3 | 1.28e-04 | 357 | 173 | 12 | IPR008271 |
| Domain | Peptidase_Metallo | 1.41e-04 | 29 | 173 | 4 | IPR006026 | |
| Domain | ZnMc | 1.41e-04 | 29 | 173 | 4 | SM00235 | |
| Domain | PROTEIN_KINASE_ST | AKT3 BMP2K MARK1 MAP3K14 MAP3K6 PASK PRKCD AKT1 MAP2K7 WNK4 WNK3 DYRK3 | 1.46e-04 | 362 | 173 | 12 | PS00108 |
| Domain | Clathrin_H-chain_linker | 2.54e-04 | 3 | 173 | 2 | IPR012331 | |
| Domain | Spermi_synthase | 2.54e-04 | 3 | 173 | 2 | IPR001045 | |
| Domain | CLH | 2.54e-04 | 3 | 173 | 2 | SM00299 | |
| Domain | Pept_M10A_Zn_BS | 3.27e-04 | 15 | 173 | 3 | IPR021158 | |
| Domain | EF-hand-dom_pair | SPTA1 SPTAN1 CAPN3 RYR3 SLC25A13 SCN8A SCN9A GCA MICU2 EFCAB7 | 3.53e-04 | 287 | 173 | 10 | IPR011992 |
| Domain | PROTEIN_KINASE_ATP | AKT3 BMP2K MARK1 MAP3K14 MAP3K6 PASK FER PRKCD AKT1 MAP2K7 WNK4 WNK3 DYRK3 | 3.59e-04 | 459 | 173 | 13 | PS00107 |
| Domain | Clathrin_a/coatomer_app_sub_C | 5.06e-04 | 4 | 173 | 2 | IPR015873 | |
| Domain | DUF3377 | 5.06e-04 | 4 | 173 | 2 | PF11857 | |
| Domain | Pept_M10A_metallopeptidase_C | 5.06e-04 | 4 | 173 | 2 | IPR021805 | |
| Domain | - | 5.06e-04 | 4 | 173 | 2 | 3.30.310.30 | |
| Domain | CYSTEINE_SWITCH | 5.51e-04 | 41 | 173 | 4 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 6.62e-04 | 43 | 173 | 4 | IPR001818 | |
| Domain | EFh | 6.84e-04 | 158 | 173 | 7 | SM00054 | |
| Domain | C2_dom | 8.52e-04 | 164 | 173 | 7 | IPR000008 | |
| Domain | Spectrin | 1.21e-03 | 23 | 173 | 3 | PF00435 | |
| Domain | Na_trans_cytopl | 1.25e-03 | 6 | 173 | 2 | PF11933 | |
| Domain | OSR1_C | 1.25e-03 | 6 | 173 | 2 | PF12202 | |
| Domain | EFhand_Ca_insen | 1.25e-03 | 6 | 173 | 2 | PF08726 | |
| Domain | Na_trans_cytopl | 1.25e-03 | 6 | 173 | 2 | IPR024583 | |
| Domain | Kinase_OSR1/WNK_CCT | 1.25e-03 | 6 | 173 | 2 | IPR024678 | |
| Domain | EF-hand_Ca_insen | 1.25e-03 | 6 | 173 | 2 | IPR014837 | |
| Domain | EF_HAND_2 | 1.43e-03 | 231 | 173 | 8 | PS50222 | |
| Domain | EF_hand_dom | 1.47e-03 | 232 | 173 | 8 | IPR002048 | |
| Domain | Clathrin | 1.74e-03 | 7 | 173 | 2 | PF00637 | |
| Domain | PI3K_Ras-bd_dom | 1.74e-03 | 7 | 173 | 2 | IPR000341 | |
| Domain | PI3K_rbd | 1.74e-03 | 7 | 173 | 2 | SM00144 | |
| Domain | PI3K_rbd | 1.74e-03 | 7 | 173 | 2 | PF00794 | |
| Domain | PI3K_RBD | 1.74e-03 | 7 | 173 | 2 | PS51546 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 1.25e-19 | 45 | 141 | 15 | MM15671 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 SPTA1 SPTAN1 SPTBN1 USP17L5 PSMD1 USP17L10 USP17L19 USP17L18 USP17L17 PIK3CA USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 5.24e-11 | 318 | 141 | 20 | MM15278 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 PSMD1 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 7.53e-11 | 191 | 141 | 16 | MM15289 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 PSMD1 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L8 USP17L13 | 6.60e-10 | 221 | 141 | 16 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 PSMD1 USP17L10 USP17L19 USP17L18 ABRAXAS2 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 1.01e-09 | 262 | 141 | 17 | MM15286 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 PSMD1 USP17L10 USP17L19 USP17L18 ABRAXAS2 USP17L17 USP17L22 USP17L15 USP17L8 USP17L13 | 7.50e-09 | 299 | 141 | 17 | M27574 |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 3.33e-07 | 46 | 141 | 7 | M46450 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.17e-06 | 55 | 141 | 7 | MM14917 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.39e-06 | 121 | 141 | 9 | M872 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 6.07e-06 | 46 | 141 | 6 | M8626 | |
| Pathway | KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY | 1.25e-05 | 108 | 141 | 8 | M9904 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.28e-05 | 31 | 141 | 5 | M877 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 1.77e-05 | 33 | 141 | 5 | M26976 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 1.77e-05 | 33 | 141 | 5 | M11725 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 2.05e-05 | 34 | 141 | 5 | MM14992 | |
| Pathway | KEGG_APOPTOSIS | 2.59e-05 | 87 | 141 | 7 | M8492 | |
| Pathway | WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY | 2.63e-05 | 18 | 141 | 4 | M42546 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 2.63e-05 | 18 | 141 | 4 | MM1549 | |
| Pathway | WP_FRAGILE_X_SYNDROME | 2.85e-05 | 121 | 141 | 8 | M39804 | |
| Pathway | WP_MAPK_SIGNALING_PATHWAY | 3.25e-05 | 160 | 141 | 9 | MM15990 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY | 3.33e-05 | 7 | 141 | 3 | M47407 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY | 3.33e-05 | 7 | 141 | 3 | M47790 | |
| Pathway | WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION | 3.49e-05 | 62 | 141 | 6 | M39429 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 3.59e-05 | 38 | 141 | 5 | MM14611 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 5.29e-05 | 8 | 141 | 3 | M47399 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 5.29e-05 | 8 | 141 | 3 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 5.29e-05 | 8 | 141 | 3 | M47395 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 5.29e-05 | 8 | 141 | 3 | M47404 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 5.29e-05 | 8 | 141 | 3 | M47405 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 5.29e-05 | 8 | 141 | 3 | M47803 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 5.29e-05 | 8 | 141 | 3 | M47715 | |
| Pathway | REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION | 5.29e-05 | 8 | 141 | 3 | M27806 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 5.29e-05 | 8 | 141 | 3 | M47482 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 5.29e-05 | 8 | 141 | 3 | M47498 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 5.92e-05 | 68 | 141 | 6 | MM14968 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 5.97e-05 | 99 | 141 | 7 | MM15905 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | CLTCL1 DSCAM SPTA1 SPTAN1 SPTBN1 LAMA2 DAG1 PSMD1 ITGA1 ADGRV1 PPP3CB AP2A1 AP2A2 PIK3CA CLTC SCN8A SCN9A | 6.09e-05 | 575 | 141 | 17 | M29853 |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 6.10e-05 | 22 | 141 | 4 | M13897 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 7.33e-05 | 23 | 141 | 4 | MM14993 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 7.87e-05 | 9 | 141 | 3 | M47397 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 7.87e-05 | 9 | 141 | 3 | M47392 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 7.87e-05 | 9 | 141 | 3 | M47391 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY | 7.87e-05 | 9 | 141 | 3 | M47402 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 7.87e-05 | 9 | 141 | 3 | M47802 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 7.87e-05 | 9 | 141 | 3 | M47490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 7.87e-05 | 9 | 141 | 3 | M47481 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 8.17e-05 | 104 | 141 | 7 | M39625 | |
| Pathway | WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS | 9.19e-05 | 46 | 141 | 5 | M39805 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | RGPD4 USP17L21 USP17L2 USP17L12 RGPD8 COPA USP17L20 USP17L11 SPTA1 SPTAN1 SPTBN1 RGPD1 DAG1 USP17L5 PSMD1 USP17L10 USP17L19 FN3K USP17L18 ABRAXAS2 MELTF USP17L17 RGPD3 USP17L6P USP17L22 FAM20A USP17L15 USP17L8 USP17L13 | 9.67e-05 | 1389 | 141 | 29 | MM15307 |
| Pathway | WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR | 1.03e-04 | 25 | 141 | 4 | M39794 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 1.03e-04 | 25 | 141 | 4 | M1547 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.12e-04 | 10 | 141 | 3 | M47400 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY | 1.12e-04 | 10 | 141 | 3 | M47401 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.12e-04 | 10 | 141 | 3 | MM15112 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY | 1.12e-04 | 10 | 141 | 3 | M47615 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 1.21e-04 | 26 | 141 | 4 | MM1371 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.46e-04 | 114 | 141 | 7 | MM15361 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 1.52e-04 | 11 | 141 | 3 | M47797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 1.52e-04 | 11 | 141 | 3 | M47403 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 1.52e-04 | 11 | 141 | 3 | M47406 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY | 1.52e-04 | 11 | 141 | 3 | M47756 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339 | 1.52e-04 | 11 | 141 | 3 | M47791 | |
| Pathway | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | 1.52e-04 | 11 | 141 | 3 | MM14694 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 1.52e-04 | 11 | 141 | 3 | M47484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 1.52e-04 | 11 | 141 | 3 | M47499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 1.52e-04 | 11 | 141 | 3 | M47501 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.69e-04 | 82 | 141 | 6 | MM15394 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 1.81e-04 | 83 | 141 | 6 | M39637 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 1.88e-04 | 29 | 141 | 4 | MM15981 | |
| Pathway | REACTOME_FLT3_SIGNALING | 1.88e-04 | 29 | 141 | 4 | MM15652 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 2.02e-04 | 12 | 141 | 3 | M47393 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350 | 2.02e-04 | 12 | 141 | 3 | M47798 | |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2 | 2.02e-04 | 12 | 141 | 3 | MM15163 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 2.02e-04 | 12 | 141 | 3 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 2.02e-04 | 12 | 141 | 3 | M47559 | |
| Pathway | REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA | 2.02e-04 | 12 | 141 | 3 | MM15105 | |
| Pathway | REACTOME_SYNTHESIS_OF_PE | 2.02e-04 | 12 | 141 | 3 | MM14586 | |
| Pathway | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | 2.02e-04 | 12 | 141 | 3 | MM15447 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 2.15e-04 | 30 | 141 | 4 | M39652 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 2.60e-04 | 13 | 141 | 3 | M47398 | |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2 | 2.60e-04 | 13 | 141 | 3 | M27415 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 2.60e-04 | 13 | 141 | 3 | M47603 | |
| Pathway | REACTOME_SYNTHESIS_OF_PE | 2.60e-04 | 13 | 141 | 3 | M656 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | AKT3 DAG1 CUBN FAAH2 SHANK2 PIK3CA SLC25A13 SCN8A SCN9A PRKCD AKT1 GRIP2 | 3.16e-04 | 367 | 141 | 12 | M48346 |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 3.29e-04 | 14 | 141 | 3 | M47390 | |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4 | 3.29e-04 | 14 | 141 | 3 | MM15161 | |
| Pathway | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | 3.29e-04 | 14 | 141 | 3 | M619 | |
| Pathway | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | 3.29e-04 | 14 | 141 | 3 | M10122 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY | 3.29e-04 | 14 | 141 | 3 | M47467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY | 3.29e-04 | 14 | 141 | 3 | M47536 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 4.08e-04 | 15 | 141 | 3 | M47389 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 4.08e-04 | 15 | 141 | 3 | MM1387 | |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4 | 4.08e-04 | 15 | 141 | 3 | M27413 | |
| Pathway | REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA | 4.08e-04 | 15 | 141 | 3 | M27360 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 4.08e-04 | 15 | 141 | 3 | M47663 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 4.08e-04 | 15 | 141 | 3 | M47475 | |
| Pathway | WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS | 4.08e-04 | 15 | 141 | 3 | M48306 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 4.90e-04 | 37 | 141 | 4 | M27847 | |
| Pathway | REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION | 4.99e-04 | 16 | 141 | 3 | M27761 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 4.99e-04 | 16 | 141 | 3 | MM15048 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 1.37e-30 | 21 | 179 | 15 | 8622927 |
| Pubmed | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 1.37e-30 | 21 | 179 | 15 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 1.37e-30 | 21 | 179 | 15 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 1.37e-30 | 21 | 179 | 15 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 1.37e-30 | 21 | 179 | 15 | 12447969 |
| Pubmed | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 1.37e-30 | 21 | 179 | 15 | 18980247 | |
| Pubmed | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 4.27e-30 | 22 | 179 | 15 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 3.25e-29 | 24 | 179 | 15 | 8995226 |
| Pubmed | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 8.08e-29 | 25 | 179 | 15 | 21115691 | |
| Pubmed | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 1.32e-28 | 33 | 179 | 16 | 20228807 | |
| Pubmed | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 1.90e-28 | 26 | 179 | 15 | 35816173 | |
| Pubmed | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 2.48e-28 | 34 | 179 | 16 | 20403174 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 2.48e-28 | 34 | 179 | 16 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 2.48e-28 | 34 | 179 | 16 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 2.48e-28 | 34 | 179 | 16 | 19188362 |
| Pubmed | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 2.48e-28 | 34 | 179 | 16 | 11941478 | |
| Pubmed | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 2.48e-28 | 34 | 179 | 16 | 17109758 | |
| Pubmed | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 2.48e-28 | 34 | 179 | 16 | 20388806 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 2.48e-28 | 34 | 179 | 16 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 2.48e-28 | 34 | 179 | 16 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 2.48e-28 | 34 | 179 | 16 | 20368735 |
| Pubmed | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 2.48e-28 | 34 | 179 | 16 | 10936051 | |
| Pubmed | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 2.48e-28 | 34 | 179 | 16 | 21448158 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 4.55e-28 | 35 | 179 | 16 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 4.55e-28 | 35 | 179 | 16 | 21239494 |
| Pubmed | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 8.16e-28 | 36 | 179 | 16 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 1.43e-27 | 37 | 179 | 16 | 20228808 |
| Pubmed | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 1.88e-27 | 29 | 179 | 15 | 32527007 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L21 USP17L2 USP17L12 USP17L20 PRAMEF22 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 5.17e-25 | 50 | 179 | 16 | 31806660 |
| Pubmed | USP17L21 ZC3H12A USP17L2 USP17L12 USP17L20 PRAMEF22 USP17L11 USP17L5 ZC3H12B ARHGAP30 USP17L10 USP17L19 DCSTAMP USP17L18 USP17L17 USP17L6P USP17L22 NNT USP17L15 WNK3 USP17L8 USP17L13 DYRK3 | 9.60e-13 | 674 | 179 | 23 | 37196079 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 7.11e-11 | 7 | 179 | 5 | 15710750 | |
| Pubmed | 4.23e-10 | 9 | 179 | 5 | 9733766 | ||
| Pubmed | 3.38e-09 | 5 | 179 | 4 | 21191416 | ||
| Pubmed | RGPD4 CLTCL1 RGPD8 COPA SPTA1 SPTAN1 SPTBN1 RGPD1 PSMD1 RGS11 HEATR1 NCOR1 RIMKLB NOP14 SHANK2 AP2A1 AP2A2 CEBPZ SLC25A13 RGPD3 CLTC SCN9A FAM169A EIF5B DLD CADPS2 RGPD5 | 6.76e-09 | 1442 | 179 | 27 | 35575683 | |
| Pubmed | AKT3 MARK1 WWP1 CAPN3 RIOK3 USP17L10 POLR3A SEMA4C MMP24 AP2A1 AP2A2 EHMT1 PRKCD AKT1 MMP1 MMP13 MMP14 WNK4 WNK3 | 8.84e-09 | 730 | 179 | 19 | 34857952 | |
| Pubmed | RGPD4 RGPD8 RGPD1 LBR POLR3A COL18A1 AP2A1 AP2A2 WASHC5 RGPD3 RGPD5 | 1.74e-08 | 215 | 179 | 11 | 35973513 | |
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 9037092 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 2.35e-08 | 7 | 179 | 4 | 11353387 | |
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 30944974 | ||
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 2.35e-08 | 7 | 179 | 4 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 2.35e-08 | 7 | 179 | 4 | 17372272 | |
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 38657106 | ||
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 21205196 | ||
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 18949001 | ||
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 25187515 | ||
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 8603673 | ||
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 26632511 | ||
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 24403063 | ||
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 23818861 | ||
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 23536549 | ||
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 12191015 | ||
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 22821000 | ||
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 20682751 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX36 COPA SPTAN1 SPTBN1 SRM PSMD1 RIOK3 MSH3 HEATR1 LBR BIRC6 POLR3A NOP14 AP2A1 AP2A2 PIK3C2A WASHC5 CEBPZ SLC25A13 EIF2B5 CLTC EIF5B PRKCD ASCC3 MMP14 | 3.37e-08 | 1353 | 179 | 25 | 29467282 |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 4.67e-08 | 8 | 179 | 4 | 21670213 | |
| Pubmed | 4.67e-08 | 8 | 179 | 4 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 4.67e-08 | 8 | 179 | 4 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 4.67e-08 | 8 | 179 | 4 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 4.67e-08 | 8 | 179 | 4 | 28745977 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 8.38e-08 | 9 | 179 | 4 | 18394993 | |
| Pubmed | 8.38e-08 | 9 | 179 | 4 | 28100513 | ||
| Pubmed | 8.38e-08 | 9 | 179 | 4 | 17887960 | ||
| Pubmed | 8.38e-08 | 9 | 179 | 4 | 11553612 | ||
| Pubmed | 8.38e-08 | 9 | 179 | 4 | 10601307 | ||
| Pubmed | 8.38e-08 | 9 | 179 | 4 | 28877029 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 10884287 | ||
| Pubmed | Temporal and spatial regulation of the phosphatidate phosphatases lipin 1 and 2. | 1.34e-07 | 3 | 179 | 3 | 18694939 | |
| Pubmed | Identification of lipidomic profiles associated with drug-resistant prostate cancer cells. | 1.34e-07 | 3 | 179 | 3 | 33596934 | |
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 30507612 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 20735359 | ||
| Pubmed | Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and exercise-induced myalgia. | 1.34e-07 | 3 | 179 | 3 | 22481384 | |
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 24634820 | ||
| Pubmed | Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. | 1.34e-07 | 3 | 179 | 3 | 17158099 | |
| Pubmed | 1.39e-07 | 10 | 179 | 4 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.39e-07 | 10 | 179 | 4 | 16332688 | |
| Pubmed | 1.39e-07 | 10 | 179 | 4 | 25898166 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.39e-07 | 10 | 179 | 4 | 8857542 | |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 1.39e-07 | 10 | 179 | 4 | 24207026 | |
| Pubmed | 1.39e-07 | 10 | 179 | 4 | 21859863 | ||
| Pubmed | TRERF1 RGPD4 RGPD8 DSCAM SPTAN1 SPTBN1 RGPD1 NCOR1 PPP3CA PPP3CB SHANK2 AP2A1 AP2A2 NETO1 RGPD3 CLTC EHMT1 ADGRA1 WNK3 ANKS1A | 1.42e-07 | 963 | 179 | 20 | 28671696 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 DHX36 RNGTT RGPD8 COPA RGPD1 SRM PSMD1 LBR BIRC6 POLR3A ABRAXAS2 NCOR1 PPP3CA PPP3CB SLC25A13 RGPD3 CLTC DLD GNAS ASCC3 MAP2K7 RGPD5 | 1.49e-07 | 1257 | 179 | 23 | 37317656 |
| Pubmed | RNGTT BMP2K SPTA1 SPTAN1 SPTBN1 ABRAXAS2 AP2A1 AP2A2 PIK3CA CLTC PRKCD | 1.52e-07 | 266 | 179 | 11 | 19380743 | |
| Pubmed | Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120. | 1.67e-07 | 25 | 179 | 5 | 15689238 | |
| Pubmed | 2.06e-07 | 26 | 179 | 5 | 24067654 | ||
| Pubmed | 2.18e-07 | 11 | 179 | 4 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 2.18e-07 | 11 | 179 | 4 | 35771867 | |
| Pubmed | 2.18e-07 | 11 | 179 | 4 | 34110283 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CLTCL1 COPA SPTA1 SPTAN1 SPTBN1 SRM PSMD1 ADH5 AP2A1 AP2A2 CLTC SCN8A EIF5B DLD DAAM2 SMS GNAS NNT | 2.21e-07 | 807 | 179 | 18 | 30575818 |
| Pubmed | Functionally distinct PI 3-kinase pathways regulate myelination in the peripheral nervous system. | 3.25e-07 | 12 | 179 | 4 | 24687281 | |
| Pubmed | 3.25e-07 | 12 | 179 | 4 | 24695638 | ||
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 3.72e-07 | 231 | 179 | 10 | 36597993 | |
| Pubmed | 4.68e-07 | 13 | 179 | 4 | 9394803 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 4.68e-07 | 13 | 179 | 4 | 31427429 | |
| Pubmed | DHX36 COPA WWP1 SPTAN1 SPTBN1 PSMD1 LBR LANCL2 ADH5 NCOR1 PPIG AP2A1 AP2A2 PIK3C2A CEBPZ PIK3CA SLC25A13 CLTC EIF5B DLD GNAS ASCC3 | 5.26e-07 | 1247 | 179 | 22 | 27684187 | |
| Pubmed | Embryonic demise caused by targeted disruption of a cysteine protease Dub-2. | 5.34e-07 | 4 | 179 | 3 | 22984479 | |
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 11138012 | ||
| Pubmed | A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages. | 5.34e-07 | 4 | 179 | 3 | 18178554 | |
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 19633290 | ||
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 26029823 | ||
| Interaction | DNAJC6 interactions | 7.37e-08 | 64 | 173 | 8 | int:DNAJC6 | |
| Interaction | WNK3 interactions | 4.95e-07 | 56 | 173 | 7 | int:WNK3 | |
| Interaction | RGPD4 interactions | 1.03e-06 | 22 | 173 | 5 | int:RGPD4 | |
| Interaction | AGAP2 interactions | SPTAN1 SPTBN1 PRAG1 PPP3CA PPP3CB SHANK2 AP2A1 AP2A2 CLTC AKT1 GNAS | 2.09e-06 | 210 | 173 | 11 | int:AGAP2 |
| Interaction | ITGB3 interactions | 2.18e-06 | 170 | 173 | 10 | int:ITGB3 | |
| Interaction | RGPD2 interactions | 3.05e-06 | 27 | 173 | 5 | int:RGPD2 | |
| Interaction | CLTB interactions | CLTCL1 BMP2K SPTAN1 SPTBN1 AP2A1 AP2A2 PIK3C2A CLTC DLD WNK3 | 4.65e-06 | 185 | 173 | 10 | int:CLTB |
| Interaction | MMP16 interactions | 1.46e-05 | 18 | 173 | 4 | int:MMP16 | |
| Interaction | MMP24 interactions | 1.84e-05 | 19 | 173 | 4 | int:MMP24 | |
| Interaction | AP2B1 interactions | AKT3 DSCAM BMP2K RGPD1 PSMD1 FAM193A AP2A1 AP2A2 PIK3C2A CLTC KIF13A WNK3 ANKS1A | 2.12e-05 | 373 | 173 | 13 | int:AP2B1 |
| Interaction | RICTOR interactions | RGPD4 DHX36 RGPD8 COPA SPTBN1 RGPD1 LBR LANCL2 POLR3A NCOR1 COL18A1 AP2A1 AP2A2 WASHC5 RGPD3 CLTC DLD AKT1 RGPD5 | 2.98e-05 | 759 | 173 | 19 | int:RICTOR |
| Interaction | REPS1 interactions | 4.88e-05 | 111 | 173 | 7 | int:REPS1 | |
| Interaction | RGPD3 interactions | 5.04e-05 | 47 | 173 | 5 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 6.18e-05 | 49 | 173 | 5 | int:RGPD1 | |
| Interaction | TTC3 interactions | 9.85e-05 | 124 | 173 | 7 | int:TTC3 | |
| Interaction | ZBTB46 interactions | 1.05e-04 | 29 | 173 | 4 | int:ZBTB46 | |
| Cytoband | 4p16.1 | USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.75e-21 | 79 | 179 | 15 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 NOP14 FAM193A USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.97e-17 | 222 | 179 | 17 | chr4p16 |
| Cytoband | Xp22.3 | 9.75e-05 | 23 | 179 | 3 | Xp22.3 | |
| Cytoband | 6q16 | 1.50e-04 | 5 | 179 | 2 | 6q16 | |
| Cytoband | 11q22.3 | 6.86e-04 | 44 | 179 | 3 | 11q22.3 | |
| GeneFamily | Lipins | 2.02e-07 | 3 | 107 | 3 | 1043 | |
| GeneFamily | EF-hand domain containing|Spectrins | 6.93e-06 | 7 | 107 | 3 | 1113 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 1.12e-05 | 24 | 107 | 4 | 891 | |
| GeneFamily | EF-hand domain containing | 4.75e-05 | 219 | 107 | 8 | 863 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 6.05e-04 | 115 | 107 | 5 | 769 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 9.49e-04 | 8 | 107 | 2 | 831 | |
| GeneFamily | Zinc fingers CCCH-type | 1.15e-03 | 35 | 107 | 3 | 73 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.22e-03 | 9 | 107 | 2 | 1203 | |
| GeneFamily | Glycosyltransferase family 8 | 1.22e-03 | 9 | 107 | 2 | 436 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 2.59e-03 | 13 | 107 | 2 | 693 | |
| GeneFamily | Sulfatases | 4.99e-03 | 18 | 107 | 2 | 410 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 AS3MT USP17L5 USP17L10 USP17L19 USP17L18 LPIN1 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 1.78e-18 | 112 | 177 | 17 | MM1095 |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 2.18e-17 | 86 | 177 | 15 | MM1312 |
| Coexpression | GERY_CEBP_TARGETS | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 2.91e-13 | 160 | 177 | 15 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 LPIN1 COL18A1 USP17L17 USP17L6P PRKCD USP17L22 PADI2 USP17L15 PCYOX1 USP17L8 USP17L13 | 1.75e-08 | 647 | 177 | 20 | MM981 |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 4.32e-07 | 43 | 177 | 6 | MM3857 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RGPD4 AMD1 AKT3 RGPD8 SPTBN1 TIGD1 RGPD1 HEATR1 RIMKLB RGPD3 EHMT1 GNAS ASCC3 MAP2K7 RGPD5 | 8.72e-07 | 474 | 177 | 15 | M40991 |
| Coexpression | KAAB_HEART_ATRIUM_VS_VENTRICLE_DN | AMD1 WWP1 SPTBN1 LAMA2 PGM1 ADH5 COQ9 DLD GNAS MPPED2 ALDH5A1 | 1.82e-06 | 262 | 177 | 11 | M2584 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 2.70e-06 | 33 | 177 | 5 | MM477 | |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP | AKT3 RNGTT DAG1 RYR3 COL18A1 PPP3CA COQ9 GCA ASTN2 ASCC3 NNT ANKS1A | 3.73e-06 | 340 | 177 | 12 | M2012 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MPP3 DSCAM ARID4A MARK1 LANCL2 FSIP2 LPIN1 MMP24 PPP3CB SHANK2 NETO1 SCN8A SCN9A FAM169A GRIP2 GNAL KIF13A MPPED2 WNK3 PDZD4 ZNF697 | 1.97e-05 | 1106 | 177 | 21 | M39071 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | AMD1 AKT3 BMP2K SPTBN1 PARVB MSH3 SSX4 PGM1 RYR3 ABRAXAS2 PPIG PPP3CA PPP3CB PIK3CA SCN9A EIF5B PRKCD NIPA2 GNAL ASCC3 MICU2 ALDH5A1 | 2.54e-05 | 1215 | 177 | 22 | M41122 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 LPIN1 COL18A1 USP17L17 TRIM17 USP17L6P PRKCD ZC3H12C USP17L22 PADI2 USP17L15 PCYOX1 USP17L8 USP17L13 | 2.92e-05 | 1226 | 177 | 22 | MM979 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 RIOK3 USP17L10 USP17L19 PGM1 USP17L18 ADH5 USP17L17 FER USP17L6P DAAM2 MMP13 USP17L22 USP17L15 USP17L8 USP17L13 | 6.27e-05 | 1198 | 177 | 21 | MM1062 |
| Coexpression | GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN | 6.31e-05 | 198 | 177 | 8 | M3325 | |
| Coexpression | GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UP | 6.53e-05 | 199 | 177 | 8 | M7821 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_DN | 6.53e-05 | 199 | 177 | 8 | M9227 | |
| Coexpression | GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP | 6.77e-05 | 200 | 177 | 8 | M3415 | |
| Coexpression | GSE19198_1H_VS_6H_IL21_TREATED_TCELL_DN | 6.77e-05 | 200 | 177 | 8 | M7232 | |
| Coexpression | GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_UP | 6.77e-05 | 200 | 177 | 8 | M7233 | |
| Coexpression | GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP | 6.77e-05 | 200 | 177 | 8 | M3675 | |
| Coexpression | GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | 6.77e-05 | 200 | 177 | 8 | M7449 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN | 6.77e-05 | 200 | 177 | 8 | M10033 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN | COPA WWP1 MSH3 PGM1 ADH5 SHANK2 PIK3C2A SLC25A13 FAM169A DLD MICU2 NNT ALDH5A1 | 1.05e-04 | 553 | 177 | 13 | M1475 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 MSH3 USP17L19 USP17L18 USP17L17 TRIM17 GRAP2 USP17L6P CDYL2 USP17L22 USP17L15 USP17L8 USP17L13 | 1.24e-04 | 1072 | 177 | 19 | MM1031 |
| Coexpression | PARENT_MTOR_SIGNALING_UP | RNGTT TRPM2 LAMA2 RCBTB2 MSH3 RBM48 MAP3K6 PPIG PPP3CA AP2A2 EIF2B5 GYG2 GNAS | 1.34e-04 | 567 | 177 | 13 | M16909 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 1.91e-04 | 363 | 177 | 10 | M41103 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | RGPD4 AKT3 RGPD8 RGPD1 LANCL2 CEMIP2 SEMA4C COL18A1 RGPD3 GCA MMP13 | 1.93e-04 | 435 | 177 | 11 | MM1221 |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 8.72e-07 | 194 | 171 | 8 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 9.06e-07 | 195 | 171 | 8 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.78e-07 | 197 | 171 | 8 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.78e-07 | 197 | 171 | 8 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.02e-06 | 198 | 171 | 8 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-06 | 200 | 171 | 8 | 9156f8fd61a833891d2f7b7fadd693b81b1e2d5a | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-06 | 200 | 171 | 8 | 566fe2e78e6f35399ec6aad5964f6d4d8ade82c6 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-06 | 200 | 171 | 8 | f11ae9055e72c938b6c9e52701478b2eee681ac4 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-06 | 169 | 171 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 4.50e-06 | 171 | 171 | 7 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | COVID-19_Mild-Neu_2|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 4.67e-06 | 172 | 171 | 7 | f5fd08b42c002d4693646b27e7b708eceb49524f | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.04e-06 | 174 | 171 | 7 | a3f4981b10afa9d41a1c66c7f98522a8a534f82b | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.04e-06 | 174 | 171 | 7 | 6cc108dde4b3f98a78a6040280f0d5e4aaa5bd75 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.04e-06 | 174 | 171 | 7 | 4b8bc5568e36031c8ecf001bb646809038c23919 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.53e-06 | 185 | 171 | 7 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.80e-06 | 186 | 171 | 7 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 8.66e-06 | 189 | 171 | 7 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 8.66e-06 | 189 | 171 | 7 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.96e-06 | 190 | 171 | 7 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.96e-06 | 190 | 171 | 7 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 9.59e-06 | 192 | 171 | 7 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.92e-06 | 193 | 171 | 7 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.92e-06 | 193 | 171 | 7 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.92e-06 | 193 | 171 | 7 | 194b49c152e3e3f599068ec88a7f0af6427b743a | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 9.92e-06 | 193 | 171 | 7 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 194 | 171 | 7 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 194 | 171 | 7 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-05 | 194 | 171 | 7 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | Epithelial-A_(AT1)|World / shred on cell class and cell subclass (v4) | 1.10e-05 | 196 | 171 | 7 | 484bbc6b1f58bc260964babb949d14f5df101393 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 197 | 171 | 7 | bed8a9b73af5caee51b1232b31c24a59353658df | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 197 | 171 | 7 | b7d5073d44aa1e2cb83ea8d8104c5ed662665755 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.25e-05 | 200 | 171 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.25e-05 | 200 | 171 | 7 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.25e-05 | 200 | 171 | 7 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.25e-05 | 200 | 171 | 7 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-05 | 200 | 171 | 7 | 6b7314c425f6b40f1301dd39cc02b0436e96a2ec | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.25e-05 | 200 | 171 | 7 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.25e-05 | 200 | 171 | 7 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.16e-05 | 146 | 171 | 6 | f7349d63bb47f1f22ced8ff514edc1c11bc782e7 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.81e-05 | 153 | 171 | 6 | d3fb83ca984c7583b1e51c364be6c7c17f67b048 | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 3.13e-05 | 156 | 171 | 6 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 3.13e-05 | 156 | 171 | 6 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 158 | 171 | 6 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.61e-05 | 160 | 171 | 6 | bb1bb3673059768c0ea0160d29fff127f3a4ecb4 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.61e-05 | 160 | 171 | 6 | 76f49b8b4450fa8acd36326bfa36a5d1f4bd95fb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-05 | 164 | 171 | 6 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-05 | 164 | 171 | 6 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.58e-05 | 167 | 171 | 6 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.58e-05 | 167 | 171 | 6 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.58e-05 | 167 | 171 | 6 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 169 | 171 | 6 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 5.06e-05 | 170 | 171 | 6 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.58e-05 | 173 | 171 | 6 | 0bc2aacae60c6d3276b0949eb0748b4ac1f56e54 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|COVID-19 / Condition, Lineage and Cell class | 5.58e-05 | 173 | 171 | 6 | 502f888b7684ed39f5c577eedcacf673ae81d39e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.53e-05 | 178 | 171 | 6 | f3b5eeca6081d65d48824b5d13e3b8eb5fdeb2dd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.53e-05 | 178 | 171 | 6 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.53e-05 | 178 | 171 | 6 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 6.73e-05 | 179 | 171 | 6 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.94e-05 | 180 | 171 | 6 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 180 | 171 | 6 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.16e-05 | 181 | 171 | 6 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.38e-05 | 182 | 171 | 6 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 7.61e-05 | 183 | 171 | 6 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 7.61e-05 | 183 | 171 | 6 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45____T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.84e-05 | 184 | 171 | 6 | 2c8e9ddce3e60302965dcf9dee77c4fe33e4071d | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 7.84e-05 | 184 | 171 | 6 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.08e-05 | 185 | 171 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 8.08e-05 | 185 | 171 | 6 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 8.08e-05 | 185 | 171 | 6 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.08e-05 | 185 | 171 | 6 | 10da5c2a92bfb3248d3f6f94a0933996326cf590 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.08e-05 | 185 | 171 | 6 | dd17025d8c423aa0a451ac7f1f301c93528e0229 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.32e-05 | 186 | 171 | 6 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 8.32e-05 | 186 | 171 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.57e-05 | 187 | 171 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Pericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 8.57e-05 | 187 | 171 | 6 | 35f25780d113f60bf4c13749013c09612ee4ff41 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-05 | 189 | 171 | 6 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-05 | 189 | 171 | 6 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-05 | 189 | 171 | 6 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 9.09e-05 | 189 | 171 | 6 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.35e-05 | 190 | 171 | 6 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | LV-08._Macrophage|World / Chamber and Cluster_Paper | 9.63e-05 | 191 | 171 | 6 | e7a0bc46ba9ba772636a583f3387748418e18832 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.63e-05 | 191 | 171 | 6 | 764c3a8829ae1253a0790744138266e81fc075ec | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.63e-05 | 191 | 171 | 6 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.63e-05 | 191 | 171 | 6 | 142f98cabf8737b28369315b3d7a0797ded88e03 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.63e-05 | 191 | 171 | 6 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 9.63e-05 | 191 | 171 | 6 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.91e-05 | 192 | 171 | 6 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.91e-05 | 192 | 171 | 6 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.91e-05 | 192 | 171 | 6 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 9.91e-05 | 192 | 171 | 6 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 9.91e-05 | 192 | 171 | 6 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 192 | 171 | 6 | a804cb101c3a5585f72217e1143584b1ca436724 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 9.91e-05 | 192 | 171 | 6 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.91e-05 | 192 | 171 | 6 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-04 | 193 | 171 | 6 | d0dcc0c11ccf99ff6b07e456d25b9742649aadd8 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 1.02e-04 | 193 | 171 | 6 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 193 | 171 | 6 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.02e-04 | 193 | 171 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 193 | 171 | 6 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 1.02e-04 | 193 | 171 | 6 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| Computational | Genes in the cancer module 210. | 1.26e-04 | 28 | 101 | 4 | MODULE_210 | |
| Drug | Dapsone [80-08-0]; Down 200; 16.2uM; PC3; HT_HG-U133A | AKT3 RNGTT SPTAN1 RCBTB2 ITGA1 CEMIP2 SEMA4C NCOR1 SCN8A GNAS MMP14 | 1.80e-07 | 195 | 164 | 11 | 5078_DN |
| Drug | N-cyclohexyl-1,3-propanediamine | 1.46e-06 | 4 | 164 | 3 | CID000018718 | |
| Drug | isoflavone | 1.92e-06 | 155 | 164 | 9 | CID000072304 | |
| Drug | AC1NBNXJ | 3.63e-06 | 5 | 164 | 3 | CID004470983 | |
| Drug | pioglitazone | CAPN3 MAP3K14 RYR3 LPIN1 NCOR1 PPIG PIK3C2A NETO1 PIK3CA GCA AKT1 MMP1 | 4.55e-06 | 326 | 164 | 12 | CID000004829 |
| Drug | n-butyl-1,3-diaminopropane | 7.22e-06 | 6 | 164 | 3 | CID000095733 | |
| Drug | AdoDatad | 7.22e-06 | 6 | 164 | 3 | CID003081160 | |
| Drug | M2 t | 7.22e-06 | 6 | 164 | 3 | CID000167321 | |
| Drug | MMI270 | 7.34e-06 | 18 | 164 | 4 | CID000446504 | |
| Drug | AC1OAGFB | CLTCL1 SPTA1 SPTAN1 SPTBN1 AP2A1 AP2A2 PIK3C2A PIK3CA GRAP2 CLTC SCN9A PRKCD AKT1 GNAL GNAS | 8.78e-06 | 539 | 164 | 15 | CID006857345 |
| Drug | library 2 | 9.24e-06 | 19 | 164 | 4 | CID005270634 | |
| Drug | magnesium | SPTBN1 LAMA2 ITGA1 ADGRV1 GBA2 PGM1 INPP4B RYR3 LPIN1 PASK MMP24 PPP3CA PIK3C2A PIK3CA GRAP2 LPIN2 EIF5B DLD PRKCD GNAL MMP1 IL1A MMP13 MMP14 NNT | 9.45e-06 | 1325 | 164 | 25 | CID000000888 |
| Drug | dimethyl selenoxide | 1.26e-05 | 7 | 164 | 3 | CID000134574 | |
| Drug | NSC226080 | TRERF1 AKT3 CLTCL1 ARID4A PSMD1 RYR3 PPIG PPP3CA PIK3C2A PIK3CA EIF2B5 CLTC EHMT1 EIF5B PRKCD AKT1 MMP1 IL1A | 1.46e-05 | 782 | 164 | 18 | CID000005040 |
| Drug | Nicardipine hydrochloride [54527-84-3]; Up 200; 7.8uM; HL60; HG-U133A | 1.46e-05 | 199 | 164 | 9 | 1600_UP | |
| Drug | Riboflavine [83-88-5]; Up 200; 10.6uM; PC3; HT_HG-U133A | 1.46e-05 | 199 | 164 | 9 | 4485_UP | |
| Drug | AC1L1AU5 | 1.70e-05 | 75 | 164 | 6 | CID000001149 | |
| Drug | MGBCP | 2.00e-05 | 8 | 164 | 3 | CID009576877 | |
| Drug | TGX-221 | 2.00e-05 | 8 | 164 | 3 | CID009907093 | |
| Drug | AC1L2954 | 2.00e-05 | 8 | 164 | 3 | CID000068150 | |
| Drug | losartan | ITGA1 ITGB6 COL18A1 MMP24 PPIG PPP3CA NETO1 PRKCD AKT1 MMP1 MMP13 MMP14 | 2.01e-05 | 378 | 164 | 12 | CID000003961 |
| Drug | bicarbonate | SLC39A2 LBR ADGRV1 BIRC6 GOT1L1 MELTF SHANK2 AP2A1 AP2A2 DLD WNK4 | 2.50e-05 | 325 | 164 | 11 | CID000000767 |
| Drug | AdoDATO | 2.99e-05 | 9 | 164 | 3 | CID000100766 | |
| Drug | YM 529 | 2.99e-05 | 9 | 164 | 3 | ctd:C087958 | |
| Drug | CGS 27023A | 2.99e-05 | 9 | 164 | 3 | ctd:C097658 | |
| Drug | glutathione reduced | SPTBN1 AS3MT FN3K ADH5 MMP24 PPIG PIK3C2A GCA DLD MMP1 IL1A MMP13 MMP14 NNT | 3.41e-05 | 534 | 164 | 14 | CID000000745 |
| Drug | oxidized glutathione | 4.13e-05 | 227 | 164 | 9 | CID000000975 | |
| Drug | BB-87 | 4.24e-05 | 10 | 164 | 3 | CID000197672 | |
| Drug | AC1L1KMJ | CLTCL1 SPTA1 SPTAN1 SPTBN1 LAMA2 COL18A1 PIK3C2A PIK3CA CLTC PRKCD AKT1 MMP1 MMP14 | 4.32e-05 | 476 | 164 | 13 | CID000030956 |
| Drug | gluconate | 4.61e-05 | 287 | 164 | 10 | CID000000604 | |
| Drug | Badg | 5.16e-05 | 2 | 164 | 2 | CID000125951 | |
| Drug | alpha-sulfone 27c | 5.16e-05 | 2 | 164 | 2 | CID011589972 | |
| Drug | colesevelam | 5.80e-05 | 11 | 164 | 3 | CID000160051 | |
| Drug | dimethyl adipimidate | 6.14e-05 | 30 | 164 | 4 | CID000025738 | |
| Drug | pirfenidone | 6.50e-05 | 138 | 164 | 7 | CID000040632 | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 6.54e-05 | 187 | 164 | 8 | 4989_DN | |
| Drug | celastrol; Down 200; 2.5uM; MCF7; HT_HG-U133A_EA | 6.54e-05 | 187 | 164 | 8 | 887_DN | |
| Drug | pyridoxal 5'-phosphate | 6.87e-05 | 301 | 164 | 10 | CID000001051 | |
| Drug | AC1MQZ6I | 7.31e-05 | 190 | 164 | 8 | CID003509873 | |
| Drug | AC1L9M3B | 7.84e-05 | 61 | 164 | 5 | CID000448562 | |
| Drug | Forskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A | 7.86e-05 | 192 | 164 | 8 | 7104_DN | |
| Drug | malolactomycin D | 7.97e-05 | 32 | 164 | 4 | CID006449115 | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; PC3; HG-U133A | 8.15e-05 | 193 | 164 | 8 | 1958_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; PC3; HG-U133A | 8.76e-05 | 195 | 164 | 8 | 1927_UP | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | 9.08e-05 | 196 | 164 | 8 | 2056_DN | |
| Drug | diacerein | 9.15e-05 | 63 | 164 | 5 | CID000026248 | |
| Drug | glycogen | AKT3 CAPN3 GCKR ADGRV1 GBA2 PGM1 PASK PIK3C2A EHMT1 DLD GYG2 AKT1 | 9.26e-05 | 443 | 164 | 12 | CID000439177 |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 7011_DN | |
| Drug | Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; PC3; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 1796_UP | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 6263_UP | |
| Drug | Moricizine hydrochloride [31883-05-3]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 3520_DN | |
| Drug | D2926_SIGMA | 9.87e-05 | 64 | 164 | 5 | CID006400050 | |
| Drug | ADPribulose | 9.95e-05 | 13 | 164 | 3 | CID000197570 | |
| Drug | formosanin C | 9.95e-05 | 13 | 164 | 3 | ctd:C067584 | |
| Drug | aminopropylcadaverine | 9.95e-05 | 13 | 164 | 3 | CID000065523 | |
| Drug | norspermine | 1.02e-04 | 34 | 164 | 4 | CID000078350 | |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; PC3; HG-U133A | 1.04e-04 | 200 | 164 | 8 | 1953_DN | |
| Drug | 4-HT | 1.14e-04 | 105 | 164 | 6 | CID005284643 | |
| Drug | AC1NRBJE | 1.19e-04 | 152 | 164 | 7 | CID005288446 | |
| Drug | diaminoguanidine | 1.26e-04 | 14 | 164 | 3 | CID000151203 | |
| Drug | Ageladine A | 1.26e-04 | 14 | 164 | 3 | ctd:C482289 | |
| Drug | homospermidine | 1.26e-04 | 14 | 164 | 3 | CID000000368 | |
| Drug | potassium hydroxide | 1.33e-04 | 108 | 164 | 6 | CID000014797 | |
| Drug | rimonabant | 1.35e-04 | 265 | 164 | 9 | ctd:C089032 | |
| Drug | spermine | AMD1 SPTA1 SPTAN1 SPTBN1 SRM FN3K ARSF PIK3C2A NETO1 PIK3CA SMS | 1.40e-04 | 394 | 164 | 11 | CID000001103 |
| Drug | alph a- | 1.41e-04 | 69 | 164 | 5 | CID000234384 | |
| Drug | aldosterone | RYR3 NCOR1 MMP24 PPP3CA SCN9A PRKCD MMP1 IL1A MMP13 MMP14 WNK4 | 1.50e-04 | 397 | 164 | 11 | CID000005839 |
| Drug | alpha-sulfone 27a | 1.54e-04 | 3 | 164 | 2 | CID009912853 | |
| Drug | alpha-sulfone 27i | 1.54e-04 | 3 | 164 | 2 | CID011620132 | |
| Drug | beta-sulfone 7a | 1.54e-04 | 3 | 164 | 2 | CID011562746 | |
| Drug | creatol | 1.54e-04 | 3 | 164 | 2 | CID000124266 | |
| Drug | alpha-sulfone 21 | 1.54e-04 | 3 | 164 | 2 | CID009822926 | |
| Drug | alpha-sulfone 13 | 1.54e-04 | 3 | 164 | 2 | CID011616500 | |
| Drug | alpha-sulfone 17 | 1.54e-04 | 3 | 164 | 2 | CID011530109 | |
| Drug | (3S)-1,1-diketo-2-[4-(4-methoxyphenyl)benzyl]thiazinane-3-carbohydroxamic acid | 1.54e-04 | 3 | 164 | 2 | CID010110960 | |
| Drug | (3S)-1,1-diketo-2-[4-(4-pyridyl)benzyl]thiazinane-3-carbohydroxamic acid | 1.54e-04 | 3 | 164 | 2 | CID009947028 | |
| Drug | 1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol | 1.57e-04 | 15 | 164 | 3 | ctd:C435044 | |
| Drug | PRODAN | 1.57e-04 | 15 | 164 | 3 | CID000028127 | |
| Drug | rhein | 1.75e-04 | 39 | 164 | 4 | CID000010168 | |
| Drug | phenylarsine oxide | 1.78e-04 | 275 | 164 | 9 | CID000004778 | |
| Drug | 5-Acetamido-5,6-Dihydro-4-Hydroxy-6-Isobutoxy-4h-Pyran-2-Carboxylic Acid | 1.85e-04 | 73 | 164 | 5 | CID011963505 | |
| Drug | x ap | 1.92e-04 | 16 | 164 | 3 | CID000065020 | |
| Drug | quercetin | LAMA2 GBA2 ADH5 MMP24 PPIG NETO1 GRAP2 AKT1 MMP1 IL1A MMP13 MMP14 | 2.03e-04 | 482 | 164 | 12 | CID005280343 |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 3.36e-25 | 46 | 164 | 16 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13 | 5.82e-22 | 69 | 164 | 16 | DOID:1682 (implicated_via_orthology) |
| Disease | myoglobinuria (implicated_via_orthology) | 1.69e-07 | 3 | 164 | 3 | DOID:0080108 (implicated_via_orthology) | |
| Disease | vulva cancer (is_marker_for) | 3.07e-05 | 2 | 164 | 2 | DOID:1245 (is_marker_for) | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 7.30e-05 | 15 | 164 | 3 | DOID:3146 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 7.94e-05 | 41 | 164 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 7.94e-05 | 41 | 164 | 4 | C0858252 | |
| Disease | B Virus Infection | 9.18e-05 | 3 | 164 | 2 | C0037140 | |
| Disease | Postherpetic neuralgia | 9.18e-05 | 3 | 164 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 9.18e-05 | 3 | 164 | 2 | C0019372 | |
| Disease | Profound Mental Retardation | 1.31e-04 | 139 | 164 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.31e-04 | 139 | 164 | 6 | C0025363 | |
| Disease | Mental deficiency | 1.31e-04 | 139 | 164 | 6 | C0917816 | |
| Disease | Megalanecephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome | 1.83e-04 | 4 | 164 | 2 | C1863924 | |
| Disease | primary biliary cholangitis (implicated_via_orthology) | 1.83e-04 | 4 | 164 | 2 | DOID:12236 (implicated_via_orthology) | |
| Disease | aortic valve stenosis (is_implicated_in) | 3.04e-04 | 5 | 164 | 2 | DOID:1712 (is_implicated_in) | |
| Disease | Endometrioid carcinoma ovary | 3.04e-04 | 5 | 164 | 2 | C0346163 | |
| Disease | Malignant neoplasm of breast | TRERF1 SPTAN1 LAMA2 CUBN MAP3K6 INPP4B NCOR1 SNX32 PIK3CA EHMT1 ASTN2 AKT1 MMP1 MMP14 MAP2K7 PDZD4 | 3.39e-04 | 1074 | 164 | 16 | C0006142 |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 4.54e-04 | 6 | 164 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | Congenital muscular dystrophy (disorder) | 4.54e-04 | 6 | 164 | 2 | C0699743 | |
| Disease | Hemimegalencephaly | 4.54e-04 | 6 | 164 | 2 | C0431391 | |
| Disease | myocardial infarction (implicated_via_orthology) | 5.07e-04 | 66 | 164 | 4 | DOID:5844 (implicated_via_orthology) | |
| Disease | Writer's Cramp | 6.33e-04 | 7 | 164 | 2 | C4316810 | |
| Disease | Ovarian neoplasm | 6.33e-04 | 7 | 164 | 2 | cv:C0919267 | |
| Disease | Dystonia Disorders | 6.33e-04 | 7 | 164 | 2 | C0393593 | |
| Disease | Idiopathic familial dystonia | 6.33e-04 | 7 | 164 | 2 | C0393598 | |
| Disease | Congenital Pain Insensitivity | 6.33e-04 | 7 | 164 | 2 | C0002768 | |
| Disease | Adult-Onset Idiopathic Focal Dystonias | 6.33e-04 | 7 | 164 | 2 | C0752198 | |
| Disease | Adult-Onset Dystonias | 6.33e-04 | 7 | 164 | 2 | C0752197 | |
| Disease | Adult-Onset Idiopathic Torsion Dystonias | 6.33e-04 | 7 | 164 | 2 | C0752199 | |
| Disease | degenerative disc disease (implicated_via_orthology) | 6.33e-04 | 7 | 164 | 2 | DOID:90 (implicated_via_orthology) | |
| Disease | Autosomal Dominant Familial Dystonia | 6.33e-04 | 7 | 164 | 2 | C0752200 | |
| Disease | Childhood Onset Dystonias | 6.33e-04 | 7 | 164 | 2 | C0752202 | |
| Disease | Autosomal Recessive Familial Dystonia | 6.33e-04 | 7 | 164 | 2 | C0752201 | |
| Disease | Dystonia, Primary | 6.33e-04 | 7 | 164 | 2 | C0752203 | |
| Disease | Dystonias, Sporadic | 6.33e-04 | 7 | 164 | 2 | C0752206 | |
| Disease | Dystonia, Secondary | 6.33e-04 | 7 | 164 | 2 | C0752205 | |
| Disease | Pseudodystonia | 6.33e-04 | 7 | 164 | 2 | C0752208 | |
| Disease | Familial Dystonia | 6.33e-04 | 7 | 164 | 2 | C0752207 | |
| Disease | Focal Dystonia | 6.33e-04 | 7 | 164 | 2 | C0743332 | |
| Disease | Malignant Neoplasms | 7.61e-04 | 128 | 164 | 5 | C0006826 | |
| Disease | Amphetamine-Related Disorders | 8.23e-04 | 75 | 164 | 4 | C0236733 | |
| Disease | Amphetamine Abuse | 8.23e-04 | 75 | 164 | 4 | C0236807 | |
| Disease | Amphetamine Addiction | 8.23e-04 | 75 | 164 | 4 | C0236804 | |
| Disease | focal segmental glomerulosclerosis (is_marker_for) | 8.41e-04 | 8 | 164 | 2 | DOID:1312 (is_marker_for) | |
| Disease | programmed cell death 1 ligand 2 measurement | 8.41e-04 | 8 | 164 | 2 | EFO_0008268 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.06e-03 | 206 | 164 | 6 | C0152013 | |
| Disease | influenza A severity measurement | 1.08e-03 | 9 | 164 | 2 | EFO_0007743 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.08e-03 | 9 | 164 | 2 | C3502809 | |
| Disease | Hamartoma Syndrome, Multiple | 1.08e-03 | 9 | 164 | 2 | C0018553 | |
| Disease | venous thromboembolism, factor VII measurement | 1.23e-03 | 38 | 164 | 3 | EFO_0004286, EFO_0004619 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.34e-03 | 10 | 164 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.34e-03 | 10 | 164 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Pseudohypoaldosteronism, Type I | 1.34e-03 | 10 | 164 | 2 | C0268436 | |
| Disease | Pseudohypoaldosteronism | 1.34e-03 | 10 | 164 | 2 | C0033805 | |
| Disease | Hyperpotassemia and Hypertension, Familial | 1.34e-03 | 10 | 164 | 2 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 1.34e-03 | 10 | 164 | 2 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 1.34e-03 | 10 | 164 | 2 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 1.34e-03 | 10 | 164 | 2 | C1449842 | |
| Disease | creatinine measurement | DSCAM MAP3K14 LAMA2 PSMD1 GCKR ADGRV1 CUBN BIRC6 COL18A1 MMP24 PPP3CA ASTN2 GNAS ASCC3 | 1.38e-03 | 995 | 164 | 14 | EFO_0004518 |
| Disease | obsolete_red blood cell distribution width | MPP3 ZC3H12A BMP2K SPTA1 RGPD1 AS3MT PARVB GCKR GBA2 BIRC6 INPP4B FN3K ITFG1 TMEM267 LPIN2 GARRE1 WNK3 | 1.40e-03 | 1347 | 164 | 17 | EFO_0005192 |
| Disease | end stage renal disease (is_implicated_in) | 1.54e-03 | 41 | 164 | 3 | DOID:783 (is_implicated_in) | |
| Disease | interstitial collagenase measurement | 1.63e-03 | 11 | 164 | 2 | EFO_0008193 | |
| Disease | hippocampal amigdala transition area volume | 1.63e-03 | 11 | 164 | 2 | EFO_0009401 | |
| Disease | phosphatidylcholine 34:1 measurement | 1.63e-03 | 11 | 164 | 2 | EFO_0010375 | |
| Disease | schizophrenia (is_marker_for) | 1.89e-03 | 44 | 164 | 3 | DOID:5419 (is_marker_for) | |
| Disease | 3-aminoisobutyrate measurement | 1.95e-03 | 12 | 164 | 2 | EFO_0010980 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.95e-03 | 12 | 164 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | esophageal cancer (is_marker_for) | 1.95e-03 | 12 | 164 | 2 | DOID:5041 (is_marker_for) | |
| Disease | abdominal aortic aneurysm (is_implicated_in) | 1.95e-03 | 12 | 164 | 2 | DOID:7693 (is_implicated_in) | |
| Disease | periodontitis (is_marker_for) | 1.95e-03 | 12 | 164 | 2 | DOID:824 (is_marker_for) | |
| Disease | risky sexual behaviour measurement | 2.60e-03 | 169 | 164 | 5 | EFO_0007877 | |
| Disease | Malformations of Cortical Development | 2.67e-03 | 14 | 164 | 2 | C1955869 | |
| Disease | thoracic aortic aneurysm (is_marker_for) | 2.67e-03 | 14 | 164 | 2 | DOID:14004 (is_marker_for) | |
| Disease | Cortical Dysplasia | 2.67e-03 | 14 | 164 | 2 | C0431380 | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 2.67e-03 | 14 | 164 | 2 | cv:C2931907 | |
| Disease | Squamous cell carcinoma of the head and neck | 3.05e-03 | 52 | 164 | 3 | C1168401 | |
| Disease | Down syndrome (implicated_via_orthology) | 3.07e-03 | 15 | 164 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | Breast Carcinoma | 3.27e-03 | 538 | 164 | 9 | C0678222 | |
| Disease | platelet component distribution width | MPP3 AKT3 BMP2K SPTA1 CUBN INPP4B FN3K COL18A1 MELTF GNAS ANKS1A | 3.43e-03 | 755 | 164 | 11 | EFO_0007984 |
| Disease | cholesteatoma of middle ear (is_marker_for) | 3.50e-03 | 16 | 164 | 2 | DOID:10964 (is_marker_for) | |
| Disease | Polyposis, Adenomatous Intestinal | 3.50e-03 | 16 | 164 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 3.50e-03 | 16 | 164 | 2 | C2713443 | |
| Disease | ovarian cancer (is_implicated_in) | 3.77e-03 | 56 | 164 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | muscular dystrophy (is_implicated_in) | 3.95e-03 | 17 | 164 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Adenomatous Polyposis Coli | 3.95e-03 | 17 | 164 | 2 | C0032580 | |
| Disease | Amelogenesis imperfecta | 3.95e-03 | 17 | 164 | 2 | cv:C0002452 | |
| Disease | fibrinogen measurement, factor VII measurement | 4.16e-03 | 58 | 164 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | glycoprotein measurement | 4.45e-03 | 119 | 164 | 4 | EFO_0004555 | |
| Disease | Bipolar Disorder | 5.37e-03 | 477 | 164 | 8 | C0005586 | |
| Disease | exercise test | 5.46e-03 | 20 | 164 | 2 | EFO_0004328 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 5.46e-03 | 20 | 164 | 2 | DOID:2526 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEDAKEIMQHRFFAG | 396 | P31749 | |
| SKHGLYGDNVEEMDS | 306 | P54793 | |
| EEAFIHFMGKGAAAE | 116 | Q9BRR6 | |
| KSQHGLYGDNVEEMD | 316 | P51689 | |
| EHGTDFFDKDGVMKD | 191 | Q15018 | |
| GSEGMKNLNFEQHFE | 891 | P29374 | |
| TSDALKAFHDMGGVQ | 3091 | Q9NR09 | |
| SFDEINKAFELMHSG | 351 | P11766 | |
| GYEEMTFHGNVDKDT | 491 | Q8IUX7 | |
| KELHGLVFQDMGFTV | 136 | Q8NHS2 | |
| LDRDHTGKMGFNAFK | 101 | P28676 | |
| SGDGDMEFFLPTIHK | 1826 | Q8WXG9 | |
| AFGALAVSQGHFLDM | 271 | Q86SQ6 | |
| FLLGHDIDFGHMEAV | 66 | O95782 | |
| EMGSALHEAALFGKT | 246 | Q92625 | |
| GFDDVHFLGSNVMEE | 721 | Q92625 | |
| SFHSADVLKMDDFGA | 1111 | Q9NSY1 | |
| SFFFDIMQHHKEGNG | 1031 | P78312 | |
| DSKFNDTLFGEMLHG | 766 | O75129 | |
| GGPDDAKEIMRHSFF | 391 | Q9Y243 | |
| FLLGHDIDFGHMEAV | 66 | O94973 | |
| HEKQADIMIFFAEGF | 171 | P50281 | |
| DLVETMKSGEHDFGA | 271 | P36871 | |
| MKSGEHDFGAAFDGD | 276 | P36871 | |
| AFDGDGDRNMILGKH | 286 | P36871 | |
| SGFAEMDHDLLKNFI | 526 | O95199 | |
| KMDEQSFFGGLLHVC | 106 | Q5RL73 | |
| KFFADGELESMGFSA | 136 | Q8TDF5 | |
| NDELSATFLEMKGHF | 276 | Q99666 | |
| NDELSATFLEMKGHF | 276 | O14715 | |
| HFMDFLGKEFSGENL | 316 | O94810 | |
| GSFLGFTDVHIRDME | 196 | Q4ADV7 | |
| DIIHDGFGFMLAFGD | 446 | Q14739 | |
| DKFAKALMHFGEHDS | 936 | Q86T65 | |
| FIGSHAFARMEGDID | 281 | Q9NXN4 | |
| GNHELTFDKEFMADL | 116 | Q15777 | |
| KEADIMIFFASGFHG | 216 | Q9Y5R2 | |
| GNYHMGFLVSEDESK | 1026 | P20585 | |
| LHMKLGDSGEAFFVQ | 76 | Q9BQK8 | |
| ALHNLDEAVKFDMGA | 156 | P01583 | |
| FENQGFFQLVMEKHG | 1071 | Q96RG2 | |
| FFQLVMEKHGSGLDL | 1076 | Q96RG2 | |
| MEKHGSGLDLFAFID | 1081 | Q96RG2 | |
| EGNFAKEVSHEMDGL | 426 | O60942 | |
| DHLFFVMEFLNGGDL | 421 | Q05655 | |
| MEIKEEGASEEGQHF | 1 | O15327 | |
| SLFEGMAGAIHFLSD | 416 | Q9NS86 | |
| FMHATDKGGLSAVDA | 576 | Q14118 | |
| LNMVFAKLEGFANGH | 1586 | Q5CZC0 | |
| DFFLEHEALGISMAK | 651 | Q13144 | |
| KDMFFSSGFQDAGHR | 361 | O95382 | |
| NGHTDMIDQDGLYEK | 486 | Q9UHG3 | |
| DADSHFGMDSKLAGI | 271 | P18564 | |
| ADIMISFGIKEHGDF | 161 | P45452 | |
| HMGFSGDFQSFVKDC | 346 | O14733 | |
| HIDFGKFLGHAQMFG | 1266 | O00443 | |
| DFHFSMDSLLAEGAG | 326 | Q76G19 | |
| FRHDKLTFIDMEGSG | 876 | P39060 | |
| VENIFHNFKGLLDGM | 111 | Q9H295 | |
| EMSHKLGDPGFVVFA | 141 | Q8N8Q9 | |
| LHMKLGDNGEAFFVQ | 76 | Q14693 | |
| KLMFHVDNGAGRFTA | 2996 | P24043 | |
| FREKQKDGHGEAIMF | 501 | Q9Y2J8 | |
| NVGAALHGFHDVMKD | 426 | Q6ZMI0 | |
| KFFGQSIHGEMDLNG | 631 | P56199 | |
| HMSADDLNDGFVLDK | 311 | P78316 | |
| IMVKDDGQLFHIDFG | 921 | P42336 | |
| VHNVSFAFELMLDGG | 316 | Q9HBI1 | |
| HRVVKDFMVQGGDFS | 66 | Q13427 | |
| RGFLIGDHSDMFNQK | 361 | Q14397 | |
| VDKVNFHMFDVGGQR | 201 | P38405 | |
| AMEHGSFDGADQGLL | 186 | O15488 | |
| NDELSATFLEMKGHF | 276 | A6NKT7 | |
| TENHGFMAKFSAEDL | 916 | O60494 | |
| AQRVKEIFGEDAMGH | 126 | Q9UG22 | |
| MKFDKDHDGLIENGG | 656 | Q9HCG7 | |
| QHMQSKGCFFLEEDG | 271 | A8K855 | |
| MGFGSDLKNSHEAVL | 1 | P16591 | |
| FAAGHDGGMIVFKLE | 306 | P53621 | |
| NMKGQFAEHLLGAGF | 796 | Q9H2U1 | |
| FDSKGSLVAMHAAGF | 546 | Q96PZ2 | |
| FLHGDDGKDEKGMNL | 626 | O15063 | |
| MEAAHFFEGTEKLLE | 1 | P17707 | |
| NGGITGHEKELMFDA | 276 | Q9HBK9 | |
| DADRFQKHGMDEFIS | 621 | Q86UW7 | |
| EMDGDKNSIFHDIDG | 941 | Q9UHN6 | |
| AHGKDFASRGIEMSE | 101 | P09622 | |
| EHDGGSFLMSKVDQD | 311 | Q6GMR7 | |
| GKDFGLHMLEDFVDS | 191 | Q9Y6X4 | |
| DGDMNIKIADFGFSN | 191 | Q9P0L2 | |
| SMFGKDGSELILHFV | 136 | O75208 | |
| MAKDILGEAGLHFDE | 1 | Q8IY31 | |
| GLFEMMLNGADAVHF | 831 | Q9H583 | |
| KDPMRHDFGFSVSDG | 946 | Q9C0E4 | |
| HQAENLLMGKEVGFF | 66 | O75791 | |
| GMFRAFHAFDKDGDG | 791 | P20807 | |
| HGQFFDLMKLFEVGG | 101 | P16298 | |
| STGFMEFDDNEGKHS | 71 | Q6UWT4 | |
| EGSAEKQAGEAHMAA | 36 | Q9H9B1 | |
| EGGALKEHFSSMDSF | 206 | P0C7U9 | |
| TVCGDIHGQFFDLMK | 86 | Q08209 | |
| IHGQFFDLMKLFEVG | 91 | Q08209 | |
| HFLDGGEMKVEQLFQ | 76 | O43781 | |
| EFGHLLDENMGSKFD | 981 | Q03701 | |
| DNTDRKGVHFLMADG | 351 | Q8N1G2 | |
| KGVHFLMADGGFSVE | 356 | Q8N1G2 | |
| GNDELSATFLEMKGH | 266 | P0DJD0 | |
| KDIEASGFNGTAAFM | 181 | Q7Z6I6 | |
| FGEVHRMEDKQTGFQ | 411 | Q99558 | |
| NHKEEMGFLRDVFSE | 26 | Q13368 | |
| EDHSFTEFMGVSEGK | 1731 | Q9H1H9 | |
| KDDFDFGTMGHVIRG | 411 | Q13423 | |
| SILDGFDHRKAMAGQ | 226 | O60469 | |
| NDELSATFLEMKGHF | 276 | Q7Z3J3 | |
| HSTLDFMLGAKADGE | 6 | P52788 | |
| GIHDAFVKAFAEAMK | 351 | P51649 | |
| QDLFGDDHNKNGFKM | 646 | P08582 | |
| GIGHKVDAVFMKDGF | 421 | P03956 | |
| MFTKFGDDGFLIHLD | 416 | Q96MK3 | |
| GESPKMFGRHFEATD | 1166 | O60841 | |
| QVDKVNFHMFDVGGQ | 856 | Q5JWF2 | |
| LMGSFDDKVEDHGVV | 2271 | O75376 | |
| FHGNDTSMDGLKDLL | 386 | A3QJZ6 | |
| HSEFELAIALMFGGF | 241 | Q9H479 | |
| GFHVAFKMLDTDGNE | 176 | Q8IYU8 | |
| HDDVMAKFGAILAQG | 721 | Q99460 | |
| EFFFHTMAGREGLVD | 846 | O14802 | |
| GFGSSVDKHLMEDSD | 1061 | Q15858 | |
| NMLTFTLEHGEFEDG | 141 | Q9C0C4 | |
| KMFLGSANFGEAAHF | 351 | A4IF30 | |
| MGHFTVLGKAFREED | 46 | P0CW24 | |
| FLGAGFMHMTAEALE | 56 | Q9NP94 | |
| GAHLDFRAKDGMTAL | 221 | Q9UPX8 | |
| GEHKEAFMDNEIDGS | 1801 | Q9UPX8 | |
| EMSGRSGHFEQAIKE | 686 | Q01082 | |
| SGHFEQAIKEGEDMI | 691 | Q01082 | |
| MENGDAGSEKDERHF | 156 | Q8N8U2 | |
| ESGAAFLFMTFHLKD | 91 | Q8N3C0 | |
| QMTEKEHGDRVFFGK | 151 | Q8N3C0 | |
| VNDFVRDKFMHKDGS | 411 | Q9UJS0 | |
| GHAASFAQFKMEGNA | 196 | Q00610 | |
| GHAAAFAEFKMEGNA | 196 | P53675 | |
| FHAYGGSMEDEKEDS | 266 | O14730 | |
| LKELGATMDGFHRSF | 741 | Q12768 | |
| DGSNVAMSHGNKEVF | 141 | Q5D1E8 | |
| FHKALAAMDSDVSDG | 351 | Q96MW7 | |
| EKGDTDIMSDLFGLH | 4271 | Q15413 | |
| MRSKRAADFHGNDFG | 71 | O60224 | |
| DMKFVSHGGIQAFLT | 726 | O94759 | |
| KGNAMVEEGHFAAED | 846 | Q13813 | |
| GKQEDAHEFLMFTVD | 156 | D6R9N7 | |
| GKQEDAHEFLMFTVD | 156 | A8MUK1 | |
| GKQEDAHEFLMFTVD | 156 | D6R901 | |
| GKQEDAHEFLMFTVD | 156 | C9JLJ4 | |
| VKHEAGIDDMFNFET | 1676 | Q9UQD0 | |
| GKQEDAHEFLMFTVD | 156 | D6RCP7 | |
| GGHENFAKMIDEAEV | 136 | Q9ULI2 | |
| SSKLTLHVGDGFEFM | 146 | P19623 | |
| LHVGDGFEFMKQNQD | 151 | P19623 | |
| GNKMVEEGHFAAEDV | 856 | P02549 | |
| EDLFMGGQKKELHFN | 971 | Q86YV5 | |
| DGSNVAMSHGNKEEF | 196 | Q5HYM0 | |
| MLEGVSNEFDHFGIS | 1 | Q86TA4 | |
| SHMGIFLDFEAGEVS | 416 | Q9Y577 | |
| AHQDSEDKGMGSDFE | 11 | Q5TEC3 | |
| GKQEDAHEFLMFTVD | 156 | C9JPN9 | |
| GKQEDAHEFLMFTVD | 156 | Q0WX57 | |
| GKQEDAHEFLMFTVD | 156 | P0C7I0 | |
| DGSNVAMSHGNKEVF | 251 | Q9C0D7 | |
| RKQGSQEGHFSEMIF | 26 | Q14585 | |
| GKQEDAHEFLMFTVD | 156 | Q6QN14 | |
| MALFHGKFIDTGFSL | 666 | Q9H0M0 | |
| QSAFADFDGDGHMDH | 261 | Q8TB96 | |
| GKQEDAHEFLMFTVD | 156 | D6RA61 | |
| GMSGLKEVDDFFEHE | 196 | Q86XE0 | |
| GKQEDAHEFLMFTVD | 156 | C9J2P7 | |
| GKQEDAHEFLMFTVD | 156 | D6RBQ6 | |
| HNSKMVTFRFDLDGD | 696 | Q96J92 | |
| DVDHFFLAGSMSLKA | 91 | Q0VDI3 | |
| GKQEDAHEFLMFTVD | 156 | D6RBM5 | |
| GKQEDAHEFLMFTVD | 156 | Q6R6M4 | |
| GKQEDAHEFLMFTVD | 156 | D6RJB6 | |
| GKQEDAHEFLMFTVD | 156 | C9JJH3 | |
| LIHEGMFISDAFGEG | 511 | Q9P1Q0 | |
| GHLGDQDFFTMIGME | 326 | Q8NBI6 | |
| FFDGIGADATHMDGD | 16 | P08048 | |
| GKQEDAHEFLMFTVD | 156 | C9JVI0 | |
| EFALHSLFEAKGDVM | 846 | Q96PN7 | |
| HNNKMVTFKFDVDGD | 766 | Q9BYP7 | |
| GESSGFMDHLEEKAD | 416 | A6NN73 | |
| LHMKLGDNGEAFFVE | 76 | Q92539 |